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ABSTRACT
IMMUNOLOGIC EVALUATION OF 
ECTOPIC GESTATION
Tawfiq A. Nasser 
Old Dominion University 
Chairs: Dr. Clare Houseman 
Dr. Robert Ratzlaff
Ectopic gestation is an error in the implantation site of the blastocyst. 
Extrauterine implantation presents a unique environment since the protective 
features of the uterus are absent. This study is an investigation into the 
immunoregulatory differences th a t  may develop as a result of a change in the 
feto-maternal junction.
The effects of female plasma on one-way mixed lymphocyte cultures and 
mitogen-stimulated cultures, anti-paternal lymphocytotoxicity, and lymphocyte 
phenotypes were determined on normal, ectopic and non-pregnant females. 
The results indicated tha t pregnant female plasma enhanced the response of 
autologous lymphocytes to spouse  and male control lymphocytes. 
Enhancement w as not seen in the mixed lymphocyte cultures from non­
pregnant, ectopic females, or unrelated males. Lymphocytes from ectopic 
females were not responsive to plasma from normal pregnant females. There 
w as no differences in the mitogen cultures and leukocyte phenotypes among 
the three pregnancy conditions. These results sugges t  the presence of some 
factor(s) in the plasma of pregnant females capable of enhancing autologous 
lymphocytes. Such factor(s) and the enhancem ent of lymphocyte responses 
seem  to be lacking in cultures from ectopic pregnantand  non-pregnantfemales.
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CHAPTER ONE 
Background of the  Problem
Introduction
Term ed "an unmitigated d isas te r  of reproduction", (Cunningham, 
MacDonald, & Gant, 1989), ectopic  pregnancy  has  been on the  rise since 
1 9 7 0  - th e  year w hen the  National Center for Health S ta tis tics  (NCHS) 
s tar ted  monitoring the condition. Ectopic pregnancy is the  clinical condition 
in which th e  b lastocyst implants in s ites  o ther than  its normal anatom ical 
site - th e  lining of the  uterine cavity . S ites  of ectopic p regnancy  are 
classified a s  tubal, ovarian, cervical or abdominal. In the  fallopian tube , the  
ampulla is the  m ost com m on area for the  occurrence  of ectopic pregnancy, 
followed by the  isthmus. Interstitial p regnancy  is the  m ost uncom m on site 
for implantation, occurring in a b o u t  3 %  of tubal pregnancies. O ther forms 
of ectopic pregnancy (Figure 1) involve th e  tubo-ovarian region, the  ovaries, 
and the  tubo-abdominal area (Cunningham e t  al., 1989).
Ectopic pregnancy is becom ing a public health burden in the  United 
S ta te s  and o ther countries ail over th e  world. High ra tes  of morbidity are 
assoc ia ted  with ectopic p regnancy  including a significant decline in the  
reproductive capabilities of w o m en , and  an increase in the  risk of ano ther  
ectopic gesta tion  (Trussed, Hatcher, C ates , S tew art ,  & Kost, 1990).
1
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: ioure 1 . Various sites of ectopic gestation
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In addition to  the  health risks a ssoc ia ted  with this condition, th e  economic 
repercussions  are by no m e a n s  less  dram atic . Using da ta  from 1 9 8 2 -1 9 8 9 ,  
W ashington  and Katz (1 9 9 1 ; 1993) estim ate  th e  indirect and  direct co s ts  
of ectopic  pregnancy to  be $1.1 billion in 199 0  or $ 9 ,4 8 2  per case . 
Moreover, 3 5 %  of th e  direct c o s ts  w ere  paid ou t of public so u rces  for 
conditions in w om en  19 years  of age  or younger, while private insurance 
paid th e  g rea ter share  in w o m en  age  2 0  or older. The g re a te s t  share  (67%) 
of indirect c o s ts  cam e from lost w a g es .  Retrospective analysis of ectopic 
p regnancy  adm issions a t  one  hospital b e tw een  the  years  1 9 7 0  - 1 9 7 4  and 
1 9 8 0  - 1 9 8 4  sh o w  an increase  in th e  incidence of ectopic p regnancy  am ong 
young , minority, unmarried, poor fem ales  with no insurance. The increase 
in incidence am ong younger w om en  is primarily due to  an  increase in 
conditions such  a s  sexually transm itted  d isease  th a t  predispose  them  to 
ectopic  pregnancy  (Krantz, Gray, D am ew ood, & Wallach, 1990).
Epidemiology and incidence 
Ectopic gesta tion  reached  an alarming rate (16.8  per 1 0 0 0  reported 
pregnancies) in 1 9 8 7 . After a slight decline in 1 9 8 8 , th e  ra te  of ectopic 
p regnancy  rose back  to  16.1 in 1 9 8 9  and approached  th e  rate  in 198 7  
(Nederlof, Lawson, Saftias , A trash , & Finch, 1990). Figures 2 and 3 
illustrate the  rise in reported  c a s e s  and  ra tes  b e tw een  the  y ears  1 9 7 0  and
3
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1 0 0  r
Year
: iqure 2 . Number of reported ectopic  p regnancies  in the  United S ta te s .  
From the  C enters  fo r Disease Control: MMWR 41 (32), 5 9 2 .
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: iqure 3 . Ectopic p regnancy  ra tes  in the  United S ta te s  (1 9 7 0 -1 9 8 9 ).  Rates 
are per 1 0 0 0  reported pregnancies  and live births and per 1 0 ,0 0 0  for 
reproductive-aged w om en  (15 -44  years). From the  Centers for Disease 
Control: MMWR. 41 (32), 5 9 2 .
5
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1 989 , respectively. Ectopic gesta tion  ra tes, how ever, m us t be analyzed 
with g rea t care. The ra tes  do not include federal hospitals, and many 
ectopic p regnancies  go undiagnosed due to  sp o n tan eo u s  resolution. 
Inconsistencies in reporting result in an imprecise a s s e s s m e n t  of the 
prevalence of ectopic  pregnancy. Using all w om en of reproductive age (15- 
4 4  years  old) m ay give the  b es t  a s s e s s m e n t  for the  incidence and 
prevalence of this condition (Doyle, DeCherney, & Diamond, 1 9 9 1 ) .  Ectopic 
pregnancies rep resen t abou t 1 .5%  of all p regnancies  in th e  United S ta tes  
and 0 .5 %  of all p regnancies  in w om en  a g es  15 - 2 4  years  (Ammerman, 
Shafer, & Snyder, 1990). Currently, complications of ectopic p regnancy  are 
the  principle c a u se  of death  during the  first trim ester and the  seco n d  leading 
cause  of dea th  assoc ia ted  with pregnancy. Death certificates filed a t  the 
NCHS sh o w  th a t  dea th  due to  ectopic  pregnancy is three  tim es greater 
am ong African-American and minority w om en  (Figure 4) than  am ong  their 
white coun terparts  (Centers for Disease Control and Prevention, 1992). 
Moran, Aral, Jenk ins , Peterman, and Alexander (1989) d em onstra te  th a t  the 
high rate of sexually transm itted  d iseases  am ong minority populations 
predispose th em  to  an increased risk of ectopic p regnancy  due to 
reproductive organ  dam age . Analysis of da ta  collected in th e  1 9 7 0 's  and 
early 1 9 8 0 's  reveal th a t  w om en  w h o  died from ectopic pregnancy 
experienced pain prior to  the  rupture of the  tube . Thirty p e rcen t died a t
6
















Figure 4 . Ectopic p regnancy  ra te s  by race and age  in th e  United S ta tes  
(1 9 70-1989). Rates are  sh o w n  per 1 0 0 0  live births, legally-induced 
abortions and ectopic pregnancies . From the  Centers for Disease Control, 
MMWR. 39(SS-4), 12.
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hom e and hem orrhage w as  the  leading c au se  of dea th  (85%  of all deaths , 
7 0 %  of which did no t have surgery). S even ty -seven  percen t of patients 
w ho  died from ectopic  pregnancy w ere  seen  by a physician and 4 9 %  were 
m isdiagnosed (Dorfman, Grimes, C ates , Binkin, Kafrissen, & O'Reilly, 1984; 
A trash, Hughes, & Hogue, 1986).
The increased ra tes  of ectopic gesta tion  is not limited to  th e  United 
S ta te s  bu t has  been  docum ented  in m any  o th e r  w es te rn  regions such  as 
Scandinavia, the  United Kingdom, and Eastern Europe (Makinen, Erkkola, & 
Laippala, 1989). Underscoring th e  high prevalence of ectopic  p regnancy  in 
the  United S ta te s ,  S tock  (1990) report th a t  b e tw een  th e  years  1 9 7 0  and 
1 9 8 0  th e  percen t maternal mortality from ectopic  p regnancy  w a s  6 .7 %  in 
Zambia, 9 .8 %  in J a p a n ,  10%  in Jam a ica ,  1 4 %  in Hong Kong a s  com pared 
with 2 0 %  in South  Carolina.
Etiology
Cunningham e t  al. (1989) divides th e  c a u s e s  of ectopic  pregnancy 
into tw o  general categories , m echanical and  functional. Included under 
mechanical c a u se s  are  disorders such  a s  salpingitis, peritubal adhesions, 
developm ental abnormalities of the  fallopian tube , previous ectopic 
pregnancy, p as t  tubal surgeries, abortions and fallopian tu b e  tum ors. All 
th e se  conditions ham per or block the  free  m ovem en t of the  ovum  or the
8
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blas tocys t th rough th e  tube . Functional e lem en ts  include altered tubal 
motility due  to  c h an g e s  in hormonal levels and  less critical conditions such  
as  m enstrual reflux and the  migration p a tte rns  of th e  ovum . C o n d i t i o n s  
such  a s  pelvic inflammatory d isease  and o ther  sexually transm itted  d iseases  
are high-risk fac to rs  fo r  ectopic gesta tion  (Krantz, Gray, Damewood, & 
Wallach, 1 990). Consequently, an increase  in hum an behaviors th a t  
facilitate th e se  clinical conditions will invariably cau se  a proportional 
increase in the  rate  of ectopic  pregnancy.
Scarring o f  th e  fimbria and tube  a cc o u n t  for m os t c a se s  of ectopic 
pregnancy. This m ay be caused  by infection, inflammation, surgery, and 
diethylstilbestrol. Chlamydia and gonorrhea are  th e  m o s t  com m on infections 
th a t  result in distortion, deciliation, and destruction  o f  th e  fimbria and tubal 
epithelium (Doyle, DeCherney, & Diamond, 1 990 ). In Finland, a study of 
1 ,0 1 7  pa tien ts  from 1 9 6 6  to  1 9 8 5  sh o w  th a t  pelvic operations, previous 
ectopic pregnancies, pelvic inflammatory d isea ses  and  the  use  of intra­
uterine devices  (IUD) are th e  m ost com m on etiologies for ectopic gestation 
(Makinen e t  al., 1989). An Italian case-control s tu d y  o f the  risk fac tors  for 
ectopic p regnancy  (Parazzini, Tozzi, Ferraroni, Bocciolone, Vecchia, & 
Fedele, 1992) confirm previous s tudies  th a t  implicate infertility, history of 
PID, and abdominal surgery  to  be am ong th e  main risk fac to rs  for ectopic 
pregnancy.
9
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Infertility d rugs and  procedures, and  therapeutic  abortions are o ther 
medical p rocedures  th a t  place female recipients in th e  high-risk group 
(Damjanov, 1 9 93 ; Cunningham et al., 1989; Suanders , Lancaster, & 
Pedisich, 1992). A s tu d y  of th e  risk of ectopic gesta tion  and its association 
with various m e th o d s  of contraception  indicate th a t  intrauterine devices are 
associated  with th e  h ighest incidence of ectopic pregnancy. However, this 
s tudy  also sh o w  th e  incidence of ectopic pregnancy to  be h ighest in w om en 
w ho do no t use con tracep tion  (Franks, Beral, Cates, & Houge, 1990). Even 
though th e  risk o f ectopic  pregnancy and contraceptive use  is an ongoing 
debate  b e tw een  researchers ,  there  is c o n sen su s  th a t  w om en  w ho do not 
use contraception have  th e  highest incidence of ectopic gesta tion  while IUD 
users have the  h ighest incidence am ong w om en using con tracep tives  
(Trussell, Hatcher, C ates ,  S tew art,  & Kostet, 1990; Franks, Beral, C ates , & 
Hogueet 1990 ; Sivin, 1 991a) .  Their results are not surprising since lUD's 
only prevent intrauterine pregnancy and do not p ro tec t fem ale  users  from 
having an extrauterine pregnancy. In addition, intra-uterine devices  do not 
prevent sexually transm itted  d iseases  and other conditions th a t  result in a 
higher risk of ectopic  gesta tion . Analysis of randomized trials of various 
kinds of intrauterine dev ices  show  th a t  the risk of ectopic  pregnancy 
depends  on the  drug and  d o se  of m edicated lUD's and on th e  age  of the  
user (Sivin, 1991 b).
10
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Pathology and diagnosis 
With all the  information p resen t regarding the  physiology of a 
successfu l pregnancy, th e  implantation s tag e  of this p rocess  is no t 
com prehensively  understood. The maternal and embryonic m echan ism s of 
both normal and abnormal pregnancies require further investigation 
(Damjanov, 1 9 93 ; Glasser, Munir, & Soares, 1 9 8 7 ; Alpin, 1991).
Ectopic gesta tion  is an error in implantation with the  m ost com m on 
anatom ical site being th e  ampulla and  is thm us of th e  fallopian tu b e .  The 
b las tocys t  ad h eres  to  and pen e tra te s  through th e  tubal m ucosa reaching the  
muscularis of the  tube. This action triggers maternal vascularization 
surrounding the  implantation site. The m ucosa  of the  fallopian tu b e  does  
not undergo a well defined decidual reaction (Cunningham e t  al., 1989).
The u te rus  undergoes  c h an g es  during ectopic  pregnancy th a t  mimic 
a normal pregnancy. Despite th e  implantation site being d istan t from the  
uterine cavity, th e  u terus under the  influence of e s trogen  and progesterone  
is converted  to  decidua. T hese  uterine c h an g e s  persist a s  long a s  the  
developing trophoblast continues to  produce and induce pregnancy  
horm ones (Damjanov, 1993).
Pelvic exam inations of sub jec ts  with ectopic  pregnancy p resen t similar 
signs of normal early pregnancy  such  as  softening of th e  cervix and  slight 
en largem ent of the  u terus. The m ost critical finding before rupture is a
11
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sausage-like m a ss  in the  adnexal region. The cul-de-sac m ay be enlarged 
and signs of peritoneal irritation m ay be p resen t if there  has  been bleeding 
within the  peritoneal cavity . Abdominal and pelvic pain are commonly seen  
in ectopic p regnancy . Vaginal bleeding is seen  a s  a result of the  sloughing 
of the  decidua indicating a failure in normal placentation. Other pelvic 
findings include te n d e rn es s  in the  adnexal region, especially upon elevating 
or moving th e  cervix (Cunningham e t  al., 19 8 9 ; Damjanov, 1993).
The early d iagnosis  of ectopic pregnancy has  been  greatly improved 
by technological refinem ents  in the  pregnancy  te s t .  Enzyme im m unoassay  
of the  be ta  subunit o f  hum an chorionic gonadotropin  (/?-HCG) is th e  m os t 
useful laboratory te s t .  T he  a b sen ce  of /?-HCG virtually ruies out viable 
trophoblast either in normal or abnormal locations. In normal pregnancy /?- 
HCG is ex pec ted  to  double every 4 8 -7 2  hours. This doubling is not seen  in 
th e  majority (67% ) of ectopic  pregnancies  (Kadar, DeVore, & Romero, 
1981; Kadar, Caldwell, & Romero, 1981 ; Kadar, & Romero, 1987). 
Cartwright (1991) reports  that/?-HCG remained below  2 0 0  mlU/mL in 7 5 %  
of ectopic p regnancies  while it m ay reach 1 5 3 ,0 0 0  mlU/ml or more in 
normal pregnancies . Progesterone has  been  recently  used  in the  diagnosis 
of ectopic p regnancy . P rogesterone  increases  in normal pregnancy. A 
decrease  in p roges terone  levels below 5ng/ml m ay indicate ectopic gesta tion  
(Stovall, Ling, C arson, & Buster, 1990).
12
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Ultrasound is a helpful too! in the  d iagnosis of ectopic  pregnancy. A 
normally s itua ted  gesta tional sac  in th e  u terine cavity excludes the  ex istence  
of an ectopic  p regnancy  ex cep t  in the  very rare c a se  w here  it may coex is t 
with a normal p regnancy. Therefore , an increase  in /?-HCG level and no 
ultrasonic ev idence  of intrauterine p regnancy  6 w eek s  or more a fte r  the  
o n s e t  of the  last m enstrual period is highly diagnostic  of ectopic pregnancy  
(Cunningham e t  a!., 1989). The c o n ce p t  of an HCG discriminatory zone is 
used  with ultrasound to  d iagnose  pa tien ts  w hen  the  HCG level is known. 
The discriminatory zone fo r abdominal u ltrasound refers to  /?-HCG levels, 
6 0 0 0 - 6 5 0 0  mlU/ml, a t  which th e  ultrasound should sh o w  an intrauterine 
gesta tional sac  in a normal p regnancy . The /?-HCG level for vaginal probe 
ultrasound is 1 5 0 0 -2 0 0 0  mlU/ml. Failure to  visualize a normal intrauterine 
implantation is highly sugges tive  o f  ectopic  gesta tion  (Kadar e t  al., 1981).
Laparoscopy is a powerful techn ique  th a t  revolutionized the  diagnosis 
and m an ag em en t of ectopic  p regnancy . Laparoscopy has  a great advan tage  
in th a t  it m ay be initiated to  rule o u t  ectopic  p regnancy  th rough an easy  and  
a ccu ra te  procedure. If ectopic  p regnancy  is seen  then  an operation to 
rem ove the  fe tu s  can  be immediately perform ed.
O ther im portant laboratory t e s t s  are  hemoglobin and hem atocrit. 
W hite blood cell co u n t  m ay be normal but in m any patien ts  an increase up 
to  30 ,000 ///l  has  been  d o cu m en ted  (Cunningham e t  al., 1989).
13
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Ectopic gesta tion  remains a public health concern due to  its high ra tes  
of morbidity and its significant mortality rates. The m o s t  com m on 
etiological fac to rs  have been identified; hence , hormonal, ultrasonographic 
and laparoscopic s tud ies  m ay be em ployed to  rule ou t ectopic  gesta tion . 
However, little is know n regarding th e  contributions of embryonic fac to rs  to 
extrauterine implantation and th e  role they  play in the  o n s e t  of ectopic 
gesta tion . Further s tud ies  comparing the  interaction of the  em bryo with the  
tubal and with th e  normal intrauterine environm ent may provide further 
information a b o u t placentation in both normal and ectopic p regnancy.
Theoretical Framework 
S om e of th e  m os t basic natural phenom ena  remain enigmatic despite  
the innovations in medical and biomedical research. None of th e se  is more 
fascinating than  th e  survival m echanism  of the  fe tus, a natural semi- 
allogeneic transp lan t in the  recipient mother.
At implantation, fetal t issue  in th e  form of trophoblast becom es  
intimately a sso c ia ted  with the  circulatory sy stem  of the  m other. Despite 
fetal expression of paternal an tigens  th a t  are foreign to the  immune sy s tem  
of the  m other, m aternal immunity remains to lerant for nine m onths .
W hat, then , are the  pathw ay(s) th a t  lead to maternal immunologic 
tolerance to w ard s  th e  fe tus?  Tolerance is defined as  the  s ta te  of lack of
14
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
immunity (Roitt, Brostoff, & Male, 1989). It is achieved through a num ber 
of different p a th w ay s  th a t  include both T and B lymphocytes. The ultimate 
result is a s ta te  of no immunity, or to lerance, to recognized self an tigens. 
In m ost transp lan ts , allogeneic or semi-allogeneic tissue  evoke an adverse  
immune response  th a t  leads to rejection of the  transplanted tissue . Fetal 
t issue, how ever, e s c a p e s  rejection by th e  maternal immune sy s tem . Fetal 
survival seem s  to  challenge curren t to lerance  theory; namely, th e  m other 
is tolerant to  non-self an tigens  during pregnancy. Part of this to le rance  is 
a ttributed to  th e  "invisibility" of trophoblastic  antigens a t th e  maternal 
interface. The inability of the  m other to  recognize fetal an tigens w a s  show n 
to  be due to  th e  lack of traditional HLA c lass  I and II antigens on the  cel! 
su rfaces  of fetal t is su e  in direct c o n ta c t  with maternal circulation 
(Sunderland, Nauem, M ason, Redm en, & Stirratet, 1981).
Even though th e  traditional HLA antigens are missing, the  t rophoblas t 
is not immunologically neutral (Sutton, M ason & Redman, 1983). T hus , the 
maternal immune sy s te m  m ust be  contributing to the  s ta te  of to lerance  
to w ard s  the  fe tus . S ince the  b la s to cy s t normally implants in th e  u te rus , it 
is possible th a t  the  intrauterine environm ent provides a unique interface th a t  
is responsible for m aternal immunomodification. Ectopic gesta tion  is a 
naturally-occurring experim ent in which the  implantation site in altered. The 
objective of the  experimental design is to  investigate changes  in maternal
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immune responses  relative to changing th e  implantation site. Ectopic 
trophoblas t invades a reas  with a relatively thin muscularis layer, com pared  
to  th e  u terus, and with incomplete decidualization a t  th e  implantation site. 
This change  in the  feto-m aternal interface m ay provide additional da ta  on 
th e  contribution of the  normal intrauterine environm ent to  fetal su cc e ss .
Immunologic a s se s sm e n t  of fem ales  with unexplained recurrent 
sp o n tan eo u s  abortion sh o w  th a t  increased sharing of HLA alleles b e tw een  
mating couples predispose the  fem ales to  miscarriage. Normal p regnant 
fem ales  do not share  a s  m any HLA alleles w ith  their m a tes  (Gerencer, 
Drazancic, Kuvacic, Tom askovic, & Kastelan, 1 9 7 9 ) .  In addition, plasm a 
from normal pregnancy contains blocking antibodies th a t  inhibit m itogen and 
mixed lymphocyte cultures. T hese  antibodies are  responsible for protecting 
th e  fe tu s  from adverse  maternal immune reactions  (Jenkins & Hancock, 
1 9 7 2 ;  Harva & Jouppila, 1977; J h a ,  Talwar, & Hingorani, 1974). The 
p resence  of anti-paternal lymphocytotoxic antibodies is an o th e r  immunologic 
fea tu re  of maternal plasm a th a t  correla tes  w ith  successfu l implantation 
(Taylor & Faulk, 1981). Finally, s tud ies  regarding leukocyte populations 
s h o w  th a t  normal T-cell populations are p resen t a t  th e  intrauterine bu t not 
a t  tubal implantation s ites  (Earl, Lunny , & Bulmer, 1987).
The aforem entioned findings regarding normal p regnancy  w ere  the  
fo cu s  of th e  immunologic evaluation of ectopic  gesta tion , and guided the
16
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
selection of the  experimental design of th is  s tudy . Mixed lym phocyte and 
m itogen cultures w ere  used  to  s tudy  HLA diversity am ong couples and the 
e f fe c ts  of immunoregulatory fac to rs  in blood plasm a. Anti-paternal 
lym phocytotoxicity  a s sa y  w a s  used  to  d e tec t  the  presence  of cytotoxic 
an tibodies in maternal serum  of th e  participating fem ales, and leukocyte 
phenotyping  w ere  com pared  am ong  th e  th ree  pregnancy conditions.
The s tudy  w a s  designed  to  explain how  cellular and  humoral 
re sp o n se s  are modified in ectopic  pregnancy  a s  com pared  to  normal 
p regnancy . In doing so , th e  s tu d y  m ay  provide data explaining the  
relationship b e tw een  th e  fe to-m aternal interface and maternal immune 
response .
Operational Definitions 
Immune function in the  s tu d y  refers to  immune responses  
m easu red  by the  mixed lym phocyte response , lymphocytotoxicity, and 
leukocyte  pheno types .
Ectopic gestation (pregnancy) is th e  e rroneous implantation of the  
b la s to cy s t  in an anatom ical site o ther  than  the  lining of the  u terus 
(Cunningham e t  al., 1 9 8 9 ,  p. 511 ) . Ectopic pregnancy in this research  
s tu d y  w a s  confirmed th rough  laparoscopic surgery.
One-way mixed lymphocyte culture (MLC) is an in vitro  t e s t  of
17
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
lym phocyte  re sp o n ses  (responders ) to  foreign or non-self lym phocytes 
incapable of grow th  (stimulators). The resultant response  of the  
proliferating population is te rm ed mixed lym phocyte response  (MLR) 
(American Society of Histocompatibility and Im m unogenetics Laboratory 
Manual (ASHI), 1 9 8 9 ,  p. 339).
Lym phocytotoxicity is th e  p resence  of com plem ent-dependen t 
an tibodies in maternal serum capable  of lysing paternal lym phocytes  (ASHI, 
1 9 8 9 ,  p. 195).
Leukocyte pheno types  are th e  different ty p es  of leukocytes circulating 
in m aternal peripheral blood (Roitt , e t  al., 1 9 8 9 . pp. 2 .4 -2 .7 ) .
Salpingitis are  infections of th e  fallopian tube  (Cunningham e t  al., 
1 9 8 9 ,  p. 739 ).
Decidua is th e  endometrium of pregnancy. It is shed  a fte r  p regnancy  
is com ple ted  (Cunningham e t  al., 1 9 8 9 ,  p 52-54).
Placentation is the p rocess  of forming a cellular s truc tu re , the  
p lacen ta , which is a ttached  to  the  inner surface  of the  u te rus  and is a venue  
for feta l nourishm ent (Cunningham e t  al., 1 9 8 9 , p. 49).
HCG Human chorionic gonadotropin  is a placenta horm one produced 
during p regnancy . It is a diagnostic  tool for ectopic gesta tion . Its increase 
indicates viable trophoblast and th e  ra te  of increase is dramatically altered 
in ectop ic  v e rses  normal pregnancy  (Cunningham e t  al., 1 9 8 9 ,  p. 70 ).
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Fimbria is the  finger-like s truc ture  of the  fallopian tu b e  proximal to the 
ovaries (Damjanov, 1 9 9 3 , p. 46).
T lymphocyte is a cell of th e  immune system  produced  by th e  thym us. 
It is capable  o f  recognizing antigens in association with HLA m olecules (Roitt 
e t  al., 1 9 8 9 ,  p. 2 .1 -2 .4 ) .
B lymphocyte is a cell of th e  immune system  th a t  is responsible for 
producing antigen-specific antibodies (Roitt e t  al., 1 9 8 9 , pp. 2 .1 -2 .7 )
IgG is a major (70-75% ) subclass  of immunoglobulins. It is a 
monomeric protein com posed  of tw o  heavy  and tw o  light chains with 
variable and co n s ta n t  regions (Roitt e t  al., 1 9 8 9 , pp. 5 .2 -5 .3 ) .
Gravidity is the  num ber of pregnancies irrespective o f  outcom e 
(Cunningham e t  al., 1 9 8 9 , pp. 2 5 7 -2 5 8 ) .
Parity is the  num ber of pregnancies th a t  resulted in delivery of a fe tus 
w ho  reached a viable s tag e  of gesta tion  (Cunningham e t  al., 1 9 8 9 ,  pp. 257- 
258).
Non-pregnant controls w ere  fem ales w ho  had tubal ligation and 
returned for tubal anastom osis .
Pregnant controls were determ ined to  be p regnant through serum 
pregnancy t e s t  (/?-HCG) and abdominal ultrasound confirmation.
PHA Phytohemagglutinin is a plant-derived protein th a t  c a u se s  non­
specific T-lymphocyte proliferation (Roitt e t  al. 1 9 8 9 ,  p. 2 .9).
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CHAPTER TWO 
Review o f th e  Literature
The s tudy  c en te rs  around th ree  major co n cep ts  in th e  field of 
reproductive immunology. The first co ncep t ad d resses  th e  expression  of 
HLA a t  th e  feto-m aternal interface. HLA are the main de te rm inan ts  of 
allograft rejection, and  their p re sen ce  or absence  on fetal t is su e  is essential 
to  understanding th e  nature  of maternal accep tance  o f  the  fe tu s .  In 
addition, this s tudy  provided MLR d a ta  which is determ ined primarily by the 
differences in the  c lass  II HLA. The second is maternal production of 
com plem ent-dependent anti-paternal lymphocytotoxic an tibody  activity. 
Trophoblastic tissue  is considered  immunogenic due to  paternally derived 
fetal antigens. Thus, the  s tudy  of maternal humoral re sp o n se  is important 
for understanding maternal to le rance  to  fetal tissue. T he  third is blood 
leukocyte populations. Differences in effector cell populations a t  the 
implantation site and in th e  peripheral circulation may play a major role in 
regulating maternal immune re sp o n ses  to  fetal an tigens. This study 
concen tra ted  on detecting  any  differences in the  ratio of m aternal leukocyte 
populations in th e  peripheral blood th a t  may occur in ectop ic  gesta tion , 
normal gesta tion  and non-pregnant fem ale controls.
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Since the  fe tu s  m ay  be considered a successfu l semi-allogeneic graft 
in th e  host m other, a d iscussion  of maternal to lerance to  foreign fetal 
an tigens  is im portant in uncovering th e  m echan ism s for fetal survival. As 
in transplantation immunology, th e  expression of HLA on both fetal and  
maternal tissue is central to  understanding  th e  nature  of th e  maternal 
immune response. Moreover, th e  mixed lym phocyte culture te s t ,  the  major 
a s sa y  in this s tudy , is a m easure  of T-lymphocyte activation by m ononuclear 
leukocyte populations a s  a result of class  II HLA disparity. Thus, a detailed 
review of the  involvement of HLA in fetal recognition is essential to  a 
com prehensive analysis of th e  da ta .
Maternal to lerance to  th e  implanted fe tu s  m ay be analyzed using tw o  
different approaches. On app roach  is studying the  immunogenicity of feta l 
t issue  and its capabilities of inducing a maternal immune response . A nother 
approach  is the  maternal immunomodifications th a t  intervene to  p ro tec t th e  
fe tu s  from the  ex pec ted  ad v erse  rejection reaction.
HLA Expression on th e  Feto-maternal Interface 
An important a sp e c t  in determining immunogenicity of fetal t issue  is 
th e  expression of HLA on th e  surface  of cells th a t  form th e  interface 
b e tw een  m other and fe tu s .  HLA have long been  established a s  th e  main 
contributors to  graft rejection. Fetal t issue  in th e  early s tag es  of gesta tion
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lack traditional HLA and , thus , it is immunologically neutral and incapable of 
eliciting an immune response  (Faulk & Temple, 19 7 6 ; Sunderland e t  al., 
1981). O ther s tud ies  d em onstra te  HLA class  II an tigens  on the  surface  of 
the  amnion which is fetal in its cellular origins and on maternal decidual cells 
from p lacen ta  of w om en  delivering a t  3 6  w e ek s  or later (Sutton, M ason, & 
Redm an, 1983). A s tudy  of HLA production in first, second , and third 
trim este r p regnancies  sh o w  th a t  HLA c lass  I an tigens  are d e tec ted  on the  
extravillous trophoblast. However, m aternal immune response  to  th e se  
an tigens  is no t d e tec te d  (Redman, McMichael, Stirrart, Sunderland, &Ting, 
1984). Transform ed and normal trophoblastic  cell lines induced with 
interferon-gam m a (INF-y) to en hance  HLA c lass  I expression are incapable 
of express ing  th e s e  an tigens  (Hunt, A ndrew s, & Gray, 1987). The 
express ion  of HLA c lass  I and II an tigens  along with /?z microglobulin on 
polyploid 2 - 8  cell-stage pre-implantation em bryos is lacking, th u s  rendering 
more ev idence  regarding the  inability of early fetal t issue  to  express  
traditional HLA (Desoye, Dohr, M otter, Winter, Urdl, Pusch, Uchanska- 
Ziegler, 84 Ziegler, 1 988 ).
The ap pearance  of HLA c lass  II an tigens  is d ep en d en t  on the  
gesta tional age  of the  con cep tu s .  Early feta! t issue  lack HLA class  II 
an tigens, but by th e  e leventh w e ek  the  p lacenta and amniochorion 
dem o n s tra te  reactivity to  anti-HLA c la ss  II antibodies. The cells of the
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placenta with the  g re a te s t  reactivity to  HLA c lass  II antibodies are 
m acrophages  (Sutton, Gadd, M ason & Redman, 1986).
Most of the  previous investigations concen tra ted  on the  extra- 
embryonic t issue  th a t  fo rm s th e  point of co n tac t  with th e  mother. The 
trophoblastic tissue  co n s ti tu te  th e  fetal contribution to  th e  feto-maternal 
interface and is ba thed  w ith maternal blood. Early trophoblastic  tissue lack 
the  expression of HLA I and II both of which are n eeded  for the  classic 
rejection reaction. While som e fetal tissue have certain non-traditional HLA 
class  I an tigens, m ost early trophoblastic tissue  lack th e  c lass  II antigens 
th a t  produce th e  more rigorous immune rejection response .
The ab sen ce  of HLA an tigens, however, d o es  n o t  solely explain fetal 
survival. The trophoblas t itself ex p resses  antigens o th e r  than  HLA antigens 
th a t  are transplantation-like an tigens  and are capable o f  eliciting an immune 
response  (Faulk & McIntyre, 1981).
Maternal t issue  in c lose proximity to  the  implantation site such  as  
epithelial glands also lack HLA c lass  II antigens but so m e  trophoblastic  fetal 
an tigens  are expressed  on th e se  tissue. Thus, the  m o ther  m ay initiate a 
m echanism  w hereby  sh e  loses recognition of self either through the  lack of 
HLA antigens  or the  p resen ce  of active suppression. A large num ber of 
endometrial g ranu locy tes  are p resen t in the  epithelial g lands near the
23
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
implantation site and  m ay play a role in the  down-regulation of maternal HLA 
on glandular epithelial cells (Johnson  & Bulmer, 1984).
Further characterization of maternal HLA class II an tigens in the 
fallopian tu b e s  of normal and  ectopic pregnant fem ales reveal th a t  in both 
conditions epithelial cells p o sse s  HLA-DR, DP, and DQ, while similar cells 
from non-pregnant fem ales  are lacking HLA-DP and DQ. The fallopian tube 
and endometrial epithelium react differently in pregnancy. Normal 
pregnancy endom etrial epithelial glands are negative fo r HLA class  II 
antigens (Johnson  & Bulmer, 1984) while fallopian tube  epithelium 
exp resses  th e se  an tigens  (Bulmer & Earl, 1987).
In sum m ary , c lass  I HLA are expressed  on som e trophoblastic  cells 
such a s  the  extravillous trophoblast bu t not on cy to trophob las t  and 
syncytio trophoblast. The class  I HLA on the  extravillous trophoblast is 
unlike the  traditional c lass  I HLA in th a t  it is not polymorphic. In addition to 
the  unusual expression of class  I HLA, fetal t issue  also exp resses  
transplantation-like trophoblastic  an tigens. Both se ts  of an tigens  contribute 
to  the  immunogenicity of th e  fe tus . Thus, modifications of the  maternal 
immune sy s tem  are im portant to unders tand  the  to lerance m echanism s of 
the  m other to w ard  the  trophoblastic  an tigens of the  implanted blastocyst.
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Lym phocyte R esponses  and  Plasma Factors  in Pregnancy 
The mixed lym phocyte culture has  been  widely used  in transplantation 
immunology to  identify compatible organ donors . It is a m easure  of T- 
lym phocyte proliferation when stimulated with a population of foreign 
leukocytes. T-lym phocyte activation is th e  result o f  disparities in th e  HLA 
class  II, mainly within th e  HLA-D region (ASHI Laboratory Manual, 1989). 
The  previous sec tion  presen ted  th e  intimate involvem ent of HLA in the  
recognition of th e  fe tu s .  As a result, th e  mixed lym phocyte  culture assay  
w a s  applied to  identify th e  effect of HLA disparities on pregnancy  ou tcom e. 
P as t  s tudies  u sed  tw o  app roaches  to  determ ine m aternal response  to  fetal 
antigens: one  w a s  th e  direct u se  of fetal cord cells a s  th e  stimulating 
population and the  o the r  w as  the  indirect m ethod of using paternal cells to 
s tudy  maternal immunity to  paternally-derived feta l an tigens .
Plasma from pregnant, primigravid w om en  a t  12 w e ek s  gestational 
age has  an inhibitory e ffec t  on mother-to-child and m other-to-unrelated  male 
MLC's. Fetal plasm a, on the  o the r  hand, inhibits mother-to-child but does  
not inhibit m other-to-m ale  MLC's (Kasakura, 1971). Plasma from pregnant 
fem ales produce similar inhibitory e ffec ts  on o ther  com binations of mixed 
lymphocyte cu ltures  be tw een  m others , fa thers , n ew b o rn s  and unrelated 
donors. T he  lym phocyte  responses  of th e  m o th e r  and fa ther to  fetal 
lym phocytes are similar. In addition, fetal cells are hyporeactive to
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stimulation with m aternal lym phocytes presumably due  to  the  production of 
in vitro  fac to rs  capab le  of blocking MLR (Ceppellini, Coppo, Miggiano, 
Pospisil, Curtoni, & Pellegrino, 1971). Plasma inhibitory e ffec ts  are not 
restricted to  allogeneic stimulation and  w ere  also seen  in PHA cultures. PHA 
responses  from non-pregnant w om en  are g rea ter  than  th o se  from pregnant 
female. Plasma from pregnant fem ales  inhibit th e  PHA response  of 
lym phocytes from non-pregnan t fem ales  (Jha e t  al., 1974).
The inhibitory e ffec ts  of plasma are due to  specific antibodies that 
block MLR. The im portance of th e se  antibodies w a s  first determ ined in 
chronic recurrent sp o n tan e o u s  aborters . W om en suffering from this 
condition lack th e  blocking antibodies th a t  are found in plasm a from normal 
pregnant fem ales . Further characterization of th e se  antibodies dem onstra te  
th a t  they  are of the  IgG c lass  and no t directed aga ins t  HLA c lass  I antigens. 
The term "blocking" w a s  given to  th e se  antibodies b e ca u se  they  are capable 
of blocking lym phocyte  proliferation in a MLC. T hus , one  fea tu re  of 
maternal to lerance  m echanism  is a humoral response  th a t  contributes  to 
fetal a ccep tan ce .  Maternal B-lymphocytes, upon c o n ta c t  with trophoblastic 
antigens produce an tibodies th a t  block allogeneic recognition (Roklin, 
Kitzmiller, Carpenter, Garovoy, & David, 1976).
Jenk ins  e t  al. (1972) show ed  th a t  lym phocyte proliferation is affected 
by the gravidity and  parity of the  w om en . Lym phocyte re sp o n ses  from
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multiparous w om en  stimulated with both fetal and paternal lym phocytes are 
lower than  th e  responses  of nulliparous w om en  stimulated with the  sam e 
cells. The addition of m aternal serum  has  no e ffec t  on lymphocyte 
re sp o n ses  of nulliparous w o m en . The re sp o n ses  of multiparous w om en 
w ere  g rea te r  w ithou t maternal serum . Thus, lym phocyte  nonresponsiveness 
in w om en  is initiated a f te r  the  first p regnancy. Similar s tudies sh o w  th a t  
lym phocytes from pregnan t w om en  are less  responsive than  those  from non­
p regnant w om en  in MLC's w h ere  the  stim ulator lym phocytes are from 
unrelated donors. Therefore, lym phocyte  nonresponsiveness  in pregnant 
fem ales is no t specific to  the  stim ulatory cell type , sp o u se  or unrelated male 
control (Jo n es  & Curzen, 1973).
Normal p regnant female lym phocyte responsiveness  to paternal 
lym phocyte stimulation is similar to  th e  re sp o n ses  to o ther male 
lym phocytes, regardless of th e  gesta tional age . Maternal lymphocyte 
responses  are similar th roughou t p regnancy  and  the  puerperium. However, 
w hen  p regnancy  plasm a from th e  second  tr im este r  is added , th e  MLR is 
inhibited. The inhibition reaches  a maximum a t  delivery and returns back  to 
normal within the  first w eek  postpar tum  (Herva e t  al., 1977). Suppressive 
capabilities of maternal serum  s ta r t  a t  2 9  w e ek s  of gesta tion  and reaches  
a maximum a t  3 6  w eek s  (Bissenden, Ling & M ackintosh, 1980). The 
inhibitory e ffec ts  are characteristic  of plasm a and no t serum of pregnant
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fem ales suggesting  a role fo r the  clotting system  in maternal inhibitory 
activity (McIntyre & Faulk, 1 979b). The suppressive capabilities of maternal 
plasma are partially due to  specific antibodies th a t  are found in the  eluates 
from hum an p lacenta . The antibodies are not anti-HLA and they  inhibit 
PHA, one- and tw o-w ay  MLC's. The antibodies are directed against some 
unknown trophoblastic  an tigens  (Faulk, J e a n n e t ,  Creighton & Carbonara, 
1974).
Later s tud ies  characterized tw o  trophoblastic  an tigens th a t  elicit 
maternal humoral responses , trophoblast antigen-1 (TA-1) and trophoblast 
antigen-2 (TA-2). The form er is a protein with som e carbohydrate  moieties 
while th e  latter is predominantly a carbohydrate  with little protein (Faulk, 
Temple, Lovins, & Smith, 1 9 7 8 ;  McIntyre & Faulk, 1 979c) . TA-1 and TA-2 
induce the  production of IgG resp o n ses .  Rabbit anti-sera prepared from TA- 
1 and TA-2 inhibit MLR, adding support to  th e  hypothesis  th a t  anti- 
trophoblastic antibodies are responsible for th e  inhibition of MLC (McIntyre 
& Faulk, 1 979a) .  Currently, e leven an tigens have been  characterized on 
trophoblastic cells. Monoclonal antibodies are p resen t for m ost of these  
antigens but there  is no antibody th a t  is specific to  trophoblast cells with no 
cross reactivity to  o ther t issue  (Anderson, Jo h n so n ,  Alexander, Jo n es ,  & 
Griffin, 1987). Other ty p es  of anti-trophoblastic antibodies are toxic to 
paternal lym phocytes. T h ese  antibodies are reactive with both trophoblast
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antigens and antigens on th e  su rface  of paternal lym phocytes. The an tigens 
th a t  share  this specificity are called trophoblast lym phocyte cross  reactive 
(TLX) antigens  (McIntyre, M cConnachie, Taylor & Faulk, 1984).
Maternal im m unotolerance to  fetal antigens also includes idiotypic- 
antiidiotypic regulation of immune responses . Pregnancy induces the 
production of site-specific antiidiotypes to  HLA-DR antibodies. The sera  of 
multiparous fem ales contain antibodies th a t  are  capable  of inhibiting 
lymphocytotoxicity by anti-HLA-DR typing sera. Thus, the  plasma of 
p regnant fem ales contain an tibodies th a t  are  capable of inhibiting the  action 
of an o th e r  s e t  of antibodies d irected against HLA-DR antigens. Further 
characterization of th e  specificities of th e se  anti-HLA-DR antibodies revealed 
th a t  th ey  are specific to  paternal HLA-DR ty p es .  The antiidiotypic antibodies 
sh o w  c ro ss  reactivity by inhibiting the  cytotoxic activity of antibodies from 
different donors. Autoantiidiotypic antibodies from pregnant fem ales are 
capable o f  blocking and binding idiotypic antibodies from o ther p regnant 
w om en  (Horini, & Terasaki, 1 9 8 2 ; Reed, Bonagura, Kung, King, & Suciu- 
Foca, 1983). Pregnancy-produced antiidiotypic antibodies react with 
au to logous lym phocytes primed with paternal lym phocytes or unrelated 
lym phocytes th a t  expressed  th e  sam e  paternal DR specificities. In addition, 
they  are capable  of significantly inhibiting MLR. The m echanism  by which 
th e se  antibodies function to  p ro tec t the  fe tu s  is still unclear bu t it is
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specu la ted  th a t  th ey  block maternal cellular and humoral responses  th a t  
could adversely  e ffec t th e  acc e p tan c e  of th e  fe tu s  (Signal, Butler, Liao, & 
Jo se p h ,  1 9 84 ; Suciu-Foca, Reed, Rohowsky, Kung, & King, 1983 ; 
Bonagura, Ma, McDowell, Lewison, King, & Suciu-Foca, 1987).
Earlier s tud ies  d em o n stra te  th e  p resence  of antibodies in the  serum of 
p regnan t w om en  th a t  are  directed agains t fetal an tigens  of paternal origin. 
The antibodies are missing in th e  serum  of w om en  w ho  suffer from 
unexplained recurrent sp o n tan eo u s  abortion. T hese  antibodies display in  
vitro  cytotoxicity  to  paternal lym phocytes and  are p resum ed  to  be necessa ry  
for th e  m ain tenance  of normal p regnancy  (Van Rood, Van Leeuwen, & 
Ernisse, 1958 ; Payne, 1 9 6 2 ;  Doughty & Gelsthorpe, 1 971) . Clinical trials 
using im m unotherapy with paternal lym phocytes  sh o w  a significant positive 
correlation b e tw een  th e  p resence  of th e se  cytotoxic  antibodies and 
successfu l p regnancy. The infusion of paternal lym phocytes  in patients with 
recurrent m iscarriages and  their s u b se q u e n t  sero-conversion improve their 
probability of a successfu l p regnancy  a s  com pared  to  pa tien ts  w ho  did no t 
sero-convert (Taylor & Faulk, 1981 ; M owbray, Gibbings, Liddell, Reginald, 
U nderwood, & Beard, 1 9 8 5 ) .  However, the  p resence  of th e se  antibodies is 
not essential for th e  s u c c e s s  of p regnancy  in general. The detection of 
cytotoxic  antibodies is variable and d ep en d s  on the  parity, gravidity, and the  
time of p regnancy  a t  which th e  blood w a s  collected (Regan & Braude, 1987 ;
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Regan, Braude & Hill, 1991). O ther s tud ies  also report th a t  cytotoxic 
antibodies are not n ecessa ry  fo r th e  m ain tenance  of a successfu l pregnancy  
(H asegaw a, T akakuw a, Adachi & K anazaw a, 1990).
In conclusion, during normal p regnancy  B-lymphocytes are induced by 
trophoblastic  an tigens  to  produce antibodies. T-lym phocytes are prevented  
from proliferation due  to  the  action of anti-trophoblastic antibodies th a t  
prevent T-cell activation and  th e  su b se q u e n t  cytotoxic reaction to  the  
implanted fetal tissue .
Immunoendocrinoloqic Regulatory Factors 
Non-specific fac to rs  such  a s  pregnancy  horm ones also contribute  to 
immunoregulation. The endocrine e ffec ts  on immune function m ay be a key 
fac to r  in understanding  fetal survival.
Progesterone which is produced  in high concen tra tion  during 
pregnancy  is considered  and im m unosuppressan t and inhibits both 
allogeneic and  m itogen lym phocyte  cu ltu res  in  vitro  a t  concen tra tions  m uch 
higher than  th o se  en coun te red  in p regnancy. P rogesterone also functions  
to  up-regulate e s trogen  recep tors  (Sitteri, Febres, C lemens, Chong, G ondes, 
& S ti te s ,1 9 7 7 ;  Clem ens, Sitteri, & S tites , 1979). T-lym phocytes p o s se s  
e s trogen  recep to rs  and  w hen  th e  recep to rs  combined with es trogen  th ey  
inhibit su p p resso r  T-cell activity (Paavonen, A nderson, & Adlercreuts, 19 8 1 ;
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Feigen, Fraser, Peterson , & Dandlikes, 1978). Thus, the  interaction of both 
these  horm ones influence humoral and  cellular immune re sp o n se s  during 
pregnancy. Furthermore, a hormone-like molecule is produced  in  vitro  a s  a 
result of allogeneic stimulation of lym phocytes. The horm one which 
resem bles chorionic gonadotropin is referred to  a s  im m unoreactive chorionic 
gonadotropin (irCG). The source  o f  this molecule is unknow n bu t it may 
play a role in regulating implantation and  protecting the  fe tu s  from rejection. 
This protection is possibly accom plished through the  inhibitory e ffec ts  high 
concentra tions of irCG has  on allogeneic activation of T-cells (Harbour- 
McMenamin, Smith, & Blalock, 1986). Conflicting results from o ther  s tudies  
show  th a t  som e pregnancy  horm ones (estrone, estradiol, estriol, 
progesterone, HCG, and hydrocortisone) are incapable of inhibiting DNA 
synthesis  in a mixed lym phocyte reaction unless added  a t  supra- 
physiological concen tra tions . Physiological concen tra tions  found in normal 
pregnancy fail to  inhibit allogeneic and mitogen-induced lym phocyte 
responses. Lym phocyte re sp o n ses  inhibited by high concen tra tion  of 
estradiol and HCG are capable  of resuming DNA synthesis  o n ce  th ey  are 
w ashed  and the  e ffec ts  of the  horm ones are removed (Schiff, Dominique, 
Merger, & Buckley, 1975).
The e ffec ts  of th e  endocrine system  in the  regulation o f  immune 
responses  in pregnancy  are ample. Hormones from p regnan t fem ales
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presen t d ichotom ous regulatory e ffec ts  on immune function depending on 
th e  concentration  and the  time a t  which they  are secreted.
Leukocytes a t  the  Implantation Site 
The immune cells which reside a t  th e  implantation site of intrauterine 
and  ectopic pregnancy are critical in determining the  maternal immune 
response . Characterization of leukocyte  populations a t  the implantation site 
m ay  support  the  hypothesis th a t  ectopic pregnancy  has  unique immunologic 
fea tu res .  The data relating to  th is  co n cep t  is limited by the  invasiveness of 
th e  p rocedures  necessary  to  obtain accu ra te  and representative sam ples . 
M ost efforts  have concen tra ted  on leukocyte populations in the  p lacenta  of 
normal pregnancy. Few stud ies  have reported on differences b e tw een  
normal and pathologic pregnancies.
Immunohistochemical techn iques  reveal th a t  term  decidua has  a large 
num ber of HLA-DR positive m acrophages  in the  basalis layer. T he  majority 
o f  T-cells within the  basalis layer exp ress  th e  T8 antigen indicating th a t  th e  
cells are of the  suppressor/cy to toxic  su b se t .  In first-trimester decidua, th e  
layers c loser to  the  trophoblast contain a large num ber o f "irregular 
m acrophages"  similar to  the  term  decidua. However, in the deeper uterine 
layers, m acrophages  are less prominent. Immature T-cell populations are 
more com m only encountered  in th e  deeper  t issue . These  immature T-cells
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are missing in th e  superficial t issue  close to  th e  fe tu s .  While th e  function 
of th e se  cells still remains unknow n, the  investigators specu la te  th a t  th ey  
provide im m unosuppressive activity capable o f inhibiting traditional immune 
re sp o n ses  (Bulmer, J o h n so n ,  & Bulmer, 1987).
Significant NK activity is found  in the  decidua, and it is restricted to  
CD56 + /CD3-/CD16- large granular lym phocytes  (LGLs). In con tras t ,  
peripheral blood m ononuclear cells have a minor population th a t  fit this 
antigenic s tructure  and th e y  exhibits w eak  NK activity. Also, there  are 
possible interactions b e tw ee n  leukocyte populations and cytokine activity 
which is p resum ed to  im pact th e  immunoregulation of p regnancy  (Ferry, 
Starky, Sargent, W att, J a c k so n ,  & Redman, 1 9 9 0 ).  There is a high ratio of 
CD3/HLA-DR+ lym phocytes  in th e  decidua o f  recurrent sp o n tan eo u s  
aborters  a s  com pared  to  ectopic  and normal pregnancy. There is no 
difference in o ther leukocytes  su b se ts  th a t  w ere  evaluated  by the  s tudy. 
The distribution of leukocyte s u b se ts  are independent of th e  em bryo 
implantation s ta tu s  and  m ay be primarily affec ted  by hormonal and cytokine 
activity (Maruyama, Makino, Sugi, M atsubayashi, O zaw a, & Nozawa, 
1992). Further reports  on th e  sam e  phenom ena sh o w  higher NK activity in 
the  decidua of a normal term  placenta  a s  com pared  to  m aternal peripheral 
blood. Moreover, p roges terone  recep tors  are n ecessa ry  fo r  the  sustaining 
the  activity of NK cells (Roussev, Higgins, & McIntyre, 1993).
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The placenta p o s s e s s e s  a unique intra-uterine immune struc ture . The 
functionality of placental leukocyte populations are different from th o se  
found in matching m aternal and  fetal peripheral blood (Goldsobel, Ank, 
Spina, Giorgi, & Stiehm , 1986). There is a difference be tw een  the 
distribution of natural killer (NK) cells in first-trim ester hum an decidua and 
the  matching maternal peripheral blood NK population. (Manaseki & Searle, 
1989).
Lymphocyte populations from mid gesta tion  have a large num ber of 
C D 3 +  cells in th e  peripheral circulation. CD16 +  and C D 2 0 +  are 
com parable  in the  blood and p lacenta  of p regnan t w om en . C D 5 6 +  are 
presen t in g rea ter  quan tities  in th e  p lacenta . There  w ere  fe w  C D 3 +  cells 
in the  p lacenta , and their role a s  it relates to  fetal immunobiology is not clear 
(Erbach, Sem ple, Milford, Goguen, O sa thanondh , & Kurnik, 1993).
The T-lineage cells bearing immature T-cell markers and E-rosette 
receptors found in th e  first tr im ester of intrauterine p regnancy  are not 
p resen t in ectopic gesta tion . Ectopic p regnancy  lacks the  normal specialized 
T-cell populations seen  in normal pregnancy. Instead, ectopic pregnancy is 
characterized by the  p re sen ce  of a  smaller classic T-lym phocyte population 
a t  its implantation site. Ectopic gesta tion  mimics intrauterine pregnancy  in 
the  p resence  of a large num ber o f  m acrophages  a t  the  implantation site. 
While the  m acrophages  a t  th e  ectopic  implantation site exp ress  HLA-DR,
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m acrophages  in the  fallopian tu b es  of normal pregnant and non-pregnant 
fem ales  do not express  HLA-DR specificities (Earl, Lunny & Bulmer, 1987). 
M oreover, endometrial epithelial t is su e  goes  through som e phenotypic 
ch an g e s  in early intrauterine g esta tion  such  a s  the  loss of HLA class  I 
d e term inan ts  (Johnson & Bulmer, 1 984) . Tubal epithelial t issue, on the  
o ther hand, does  no t sh o w  th e se  c h a n g e s  in ectopic  pregnancy  (Bulmer & 
Earl, 1987).
S tudies  on maternal cellular and  humoral responses  are founded on 
d a ta  from studies  with variable designs . Therefore, analysis o f  the  literature 
m u s t  be done with careful a tten tion  to  the  details of th e  experimental 
designs. Som e researchers  use se rum , o the rs  use  plasm a. There w as  
a lw ays  a difference in th e  gesta tional age  of th e  pregnant w om en . The 
num ber of patients  used  w a s  variable even  within one s tudy  and the  
m athem atical representation of MLC da ta  w a s  different am ong various 
s tud ies . In general th e  experim ental design of m ost s tud ies  differed 
sufficiently and rendered a body of d a ta  th a t  is inadequate  to  co n s tru c t  a 
co n cre te  theoretical model. The p henom ena  regarding the  inhibitory e ffec ts  
of p regnancy  plasma on mixed lym phocyte  culture d ep en d s  on the 
m athem atical equation used  to  p re sen t  MLC d a ta  (Park, Edwin, Sco tt ,  & 
W are-Branch, 1990). Coulam (1992) reviewed data  from a num ber of 
immunological a ssa y s  including MLC and  their application in reproductive
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immunology and concluded th a t  results  w ere  variable from th e se  a ssa y s  and 
d epended  on the  duration of pregnancy, num ber of pregnancies, and 
multiple fac to rs  within the  experim ental designs.
Maternal immunoregulatory m echanism s during p regnancy  are diverse 
including cellular, humoral, and  endocrinological fac to rs . The 
in terdependence  of m any of th e se  m echanism s, collectively, result in the  
protection of the  fe tu s . While m any  of th e  fac ts  surrounding maternal 
im m unotolerance to w ard s  fetal t issue  have been described, the  ex ac t 
c a sc a d e  of e v en ts  following intrauterine implantation th a t  leads to  tolerance 
of th e  fe tu s  is no t know n. Therefore , s tud ies  th a t  characterize  maternal 
immune function in pathologic pregnancies  w here  th e  intact ne tw ork  of 
maternal regulatory fac to rs  is d isrupted m ay reveal a w ealth  of information 
regarding the  immunoregulation o f  normal intrauterine pregnancy.
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T he s tudy  followed th e  design o f o ther immunologic s tud ies  aimed a t 
understanding clinical conditions such  a s  unexplained sp o n tan eo u s  
abortions. None of the  literature provides conclusive data  regarding the  
relationship b e tw een  m aternal immunity and ectopic gesta tion. T he  design 
of this s tudy  w a s  exploratory in nature  and aimed a t  providing g rea ter  
characterization of maternal immunologic responses  in ectopic pregnancy. 
Moreover, since ectopic gesta tion  m ay be considered a unique natural 
experim ent w here  the  implantation site is altered, the  research m ay  aid in 
understanding the  role of th e  u terus in the  m ain tenance  of successfu l 
p regnancy.
It is unknow n w h e th e r  ectopic  pregnancy exhibits th e  sam e 
immunologic fea tu re s  a s  normal pregnancy. The evaluation of ectopic 
gesta tion  will ad d ress  the  humoral and  cellular immune responses  and  how  
they  com pare  to  th e  immunologic fea tu re s  of normal pregnancy. The 
research  objectives are fo cu sed  on th e  alterations in maternal immune 
response  th a t  result from a ch an g e  in th e  implantation site of the  fe tu s .
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S ta te m e n t  of Research Objectives
1- Is there  a difference in th e  mixed lym phocyte  response  of fem ales  
with any  of the  th ree  p regnancy  conditions to  their male sp o u se  
versus  unrelated male controls? This question  a d d re sse s  the  role HLA 
sharing be tw een  mating couples play in p regnancy  ou tcom e. It is 
aimed a t  determining w h e th e r  fem ales  with ectopic  pregnancy  have  
a d isproportionate sharing of HLA alleles with their male sp o u se s  as  
com pared  to  unrelated males.
2- Is there  an inhibitory or stimulatory e ffec t  of plasma from the  th ree  
p regnancy  conditions on th e  mixed lym phocyte  response?  One of the  
imm unoregulatory fe a tu re s  of p regnancy  is th e  p resence  of MLR 
blocking fac to rs  in m aternal plasm a. A s tudy  of plasma e ffec ts  in 
ectopic  pregnancy  will determ ine w h e th e r  this regulatory fea tu re  is 
characteristic  of normal pregnancy  only, or is it modified with a 
change  in the  implantation site.
3- Is there  a difference in the  plasm a e ffec ts  on PHA-stimulated 
lym phocyte cultures and  male-to-male MLR? This question add ressed  
the  specificity of plasm a effec ts .  Are th e se  e ffec ts  only seen  in 
fem ale lym phocyte re sp o n ses  or does  it ex tend  to  male lym phocyte 
responses?  And, are th e  plasma e ffec ts  specific to  MLC or, are th ey  
seen  w hen  th e  m ode of lym phocyte stimulation changes?
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4- Do fem ales  with ectop ic  gesta tion have any  com plem ent-dependen t 
anti-paternal lym phocytotoxic antibodies? In vitro  cytotoxic 
antibodies are a n o th e r  probable im m unoregulatory fea tu re  of normal 
pregnancy. It is unknow n w h e th er  th e y  are  d e tec ted  in ectopic 
pregnancy.
5- Is the  maternal peripheral lymphocyte p h eno type  different am ong the 
th ree  p regnancy  o u tco m es?  This question e x p an d s  on the finding 
th a t  leukocyte populations are different a t  th e  normal versus tubal 
implantation site. It investigates w h e th e r  the re  are differences in 
circulating leukocyte  populations.
Hypothesis
The general hypo thesis  w a s  formulated a s  a subs tan tive  hypothesis 
th a t  w a s  then  sub-divided into statistical h y p o th e se s  (Kerlinger, 1986). 
S ubstan tive  Hypothesis
There is a difference in the  immune function of ectopic pregnant, 
normal p regnan t and  non-pregnant fem ales.
Statistical H ypotheses
Mixed lym phocyte culture assay:
1) Ha: There is a difference in th e  m ean %RR of female
lym phocytes  am ong the  th ree  conditions with no plasm 
a added .
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H0: There is no difference in th e  m ean %RR of female
lym phocytes  am ong the  three conditions with no plasm 
a added .
2) Ha: There  is a difference in the  m ean  %RR of male spouse
lym phocytes am ong the  three conditions with no plasm 
a added .
H0: There is no difference in the m ean %RR of male spous
e lym phocytes  am ong the  th ree  conditions with no 
plasm a added .
3) Ha: There is a difference in the  m ean SI of female MLR's
am ong th e  th ree  conditions, tw o  stimulating cell types, 
and five p lasm a types.
H0: There is no difference in the m ean SI o f  female MLR's
am ong th e  th ree  pregnancy conditions, tw o  stimulating 
cell ty p es ,  and five plasma types.
4) Ha: There  is a difference in the m ean SI of male-to-male
MLR's am ong  the  five plasma types .
H0: There is no difference in the m ean  SI of male-to-male
MLR's am ong  the  five plasma types .
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Mitogen stimulation assay :
Ha: There is a difference in th e  m ean PHA SI of female
lym phocytes am ong the th ree  pregnancy conditions an
d five plasma types .
H0: There is no difference in th e  m ean PHA SI of female
lym phocytes am ong the  th ree  pregnancy  conditions an
d five plasm a types.
Cytotoxicity assay:
Ha: There is a difference in maternal cytotoxic activity
against paternal lym phocytes am ong th e  three  pregnancy  
conditions.
H0: There is no difference in maternal cytotoxic activity
against paternal lymphocytic an tigens  am ong th e  th ree  
pregnancy conditions.
Lymphocyte pheno types  :
Ha: There is a difference in the  pheno type  ratios am ong the
three  p regnancy  conditions.
H0: There is no difference in the  pheno type  ratios am ong the
three  p regnancy  conditions.
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Sampling
A sam ple of conven ience  consisting of pa tien ts  and  controls  w a s  
selected from Portsm outh  Naval Hospital (PNH). All pa tien ts  signed an 
informed c o n sen t  w hich  remains in their file a t  th e  Naval Hospital. The 
experimental protocol w a s  reviewed and  approved by th e  Com m ittee  for 
Protection of Human Sub jec ts  a t  th e  Naval Hospital in Portsm outh , Virginia.
All the  participants w ere  classified in acco rd an ce  with their pregnancy 
condition. Upon final analysis the re  w ere  tw elve  ectopic, nine normal 
pregnant, and ten  m ultiparous non-pregnant fem ales. The average  a g es  
w ere 3 2  years  for th e  non-pregnant group, 2 9  years  for th e  p regnan t group 
with a mean gravidity of 2 and parity of 0 .7 ,  and 2 8  years  fo r th e  ectopic 
group with a m ean gravidity of 2 .8  and parity of 1. The gesta tional age 
ranged for normal p regnan t fem ales  from 4 - 7  w e ek s  w ith a  m ean of 6 
w eeks , and for ectopic  p regnan t fem ales  from 3 - 8  w eek s  with a m ean of 
5 w eeks. The general health of th e  participants w a s  good with no known 
viral or bacterial infections and no know n conditions th a t  m ay cause  
immunodeficiency. Non-pregnant controls  consis ted  of fem ales  w ho  had 
received tubal ligations and  returned to  th e  hospital for tubal anas tom osis .  
Three unrelated male controls w ere  included in th e  MLC and  cytotoxic 
assay .
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M ethod Reliability and Validity
Reliability
Precision of all m e thods  w a s  te s te d  by replicating th e  m easurem en t 
of each  da ta  point. In th e  mixed lym phocyte culture, th e  sam e  cell reaction 
w a s  te s te d  in th ree  sep a ra te  wells. The m ean coefficient of variation w a s  
0 .5 8 8 % .  Furthermore, the  intensity  of the  MLR is d ep en d e n t  on the  num ber 
of non-identical HLA haplo types. Lymphocyte populations with tw o  
identical HLA haplo types have a lower MLR than  populations with one 
identical HLA haplotype. MLC's with non-identical hap lo types  have the 
g rea te s t  MLR's. Hence, th e  mixed lym phocyte  culture is reliable in detecting 
differences in HLA and is a functional m easure  of cellular immunity (Bain, 
Vas, & Lowenstein, 1964 ; Bach & Hirschhorn, 1964).
Each reaction in th e  cy to toxic  a s sa y  w a s  s e t  up in duplicate  and  there  
w a s  no significant difference b e tw een  the  first and the  seco n d  duplicated 
wells indicating th a t  the  a s sa y  w a s  precise. The leukocyte pheno type  a ssay  
w a s  run in duplicate using tw o  different m ethods  and  there  w ere  no 
differences in the  results  obtained  by th e  tw o  determ inations. Moreover, all 
the  a s s a y s  u sed  in this s tudy  followed th e  protocols of th e  American Society  
of Histocompatibility and Im m unogenetics  (ASHI Laboratory Manual, 1989) 
which are  approved by th e  Food and Drug Administration fo r  patien t testing 
and diagnosis.
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Cellular, m itogen, and  mitomycin-C quantities w ere  sub jec ted  to  dose- 
response  ana lyses  to  determ ine the  m ost effective  com binations to  yield 
optimal results (Appendix A). The num ber of cell w a sh e s ,  the  effec t of 
collection and th e  s to rag e  of cells w ere also a s s e s s e d  in th e  appropriate 
a s sa y s  to control for variability.
Validity
Validity of all experim ents  w as  dem o n stra ted  by using internal 
controls. T h ese  control cu ltures  w ere  introduced into each  a ssay  to 
determ ine if th e  cells w e re  capab le  of responding in the  expec ted  fashion 
under control conditions, in th e  mixed lym phocyte culture, an  auto logous 
one-w ay  MLC (both stim ulator and  responder cells are  from the  sam e 
participant) w a s  introduced to  give a base-line reading for each  of the  
responder cell ty p es .  Individual lym phocytes do  no t proliferate w hen  
challenged with an  au to logous  population of lym phocytes. All reactions th a t  
sh o w ed  proliferation in th e  au tologous, base-line, control and  read higher 
than  mixed lym phocyte reactions  w ere  dropped from th e  final analysis. The 
mitogen PHA w a s  u sed  a s  a positive control to  d em o n s tra te  th e  ability of 
cultured lym phocytes to  respond to  non-specific, polyclonal, stimulation. 
Any a ssay  w here  the  control wells show ed general inhibition with mitogen 
stimulation w ere  d ropped  from the  data se t. PHA added  to  mitomycin- 
trea ted  cells served  a s  a negative  control and d em o n stra ted  th a t  th e se  cells
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w ere  incapable of proliferation. The media quality control described in th e  
m ethods  section ensured  th a t  data w a s  no t m isrepresented due to  
contam ination with fungal or bacterial e lem ents .
The validity of the  cytotoxic data  w a s  a lso verified through the  use  of 
positive and negative controls. A commercially prepared antibody to  hum an 
lym phocytes (Pelfreeze) w a s  used as  a positive control and tw o  wells 
including cells, media, and com plem ent w ere  used  a s  a negative control.
S tudies  done a t  W alter Reed Medical C enter w ere  determined to  be 
valid in a cco rd an ce  with the  policies of the  laboratory which follow the  
m andated  governm ental regulation for quality control.
A ssum ptions and Limitations
A ssum ptions  referred to in this section are  th o se  conditions th a t  w ere  
beyond the  control of the  investigators, and w ere  a ssu m e d  to be c o n s ta n t  
through the  s tudy . Limitations are the  various restrictions and controls th a t  
w ere  selec ted  a priori.
A ssum ptions :
1) All pregnancies  w ere  assum ed  to  be the  product of mating 
b e tw een  the  couples identified a s  husband  and  wife.
2) Control and experimental groups w ere  free of any medical or 
physical conditions th a t  may e ffec t  their immune responses.
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3) All cu ltures  w ere  free of contam inants  and all experimental 
s y s te m s  w ere  sterile.
4) Paternal an tigens  are capable of eliciting th e  sam e maternal 
imm une re sp o n se  a s  fetal antigens of paternal origin.
Limitations:
1) The s tudy  population w a s  non-random which limited the  use  of 
inferential s ta tis tics .
2) All th e  participants w ere  drawn from one population of active 
duty , and  reserve naval personnel and their dependen ts .
3) Pooled plasm a and cells w ere  the  product o f  no more than
th ree  controls.
4) The definition of immune function w a s  restricted to  the
m easure  of the  mixed lymphocyte responses , the
lym phocytotoxic activity in maternal serum , and  th e  leukocyte 
phenotypes .
5) No unrelated fem ales w ere  introduced into th e  experimental
design to  control for the  response of male sp o u se  lym phocytes 
to  their respective  female lymphocytes.
6 ) The leukocyte phenotype  enumeration w a s  limited to  a selected 
num ber of com m on types.
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A ssay  T echniques  
O ne-w ay Mixed Lym phocyte and Mitoaen Stimulation Cultures
Objective. To determ ine differences in lym phocyte  proliferation (using 
both allogeneic and  mitogen stimulation) b e tw een  th e  various pregnancy 
o u tco m es  due  to  HLA antigen sharing; and  to  determ ine any inhibitory or 
stimulatory e ffec ts  o f  plasma obtained from th e  different pregnancy 
conditions on th e  MLR.
Background and principle. The  mixed lym phocyte  culture w a s  first 
encoun te red  w h en  a group of scientis ts  noticed th e  developm ent of large 
immature cells w hen  blood sam ples from tw o  leukemic patients w ere  
accidentally mixed (Scherk and Donnelly, 1 9 6 1 ) .  Further s tudies  (Bain, Vas, 
& Lowenstein, 1 9 6 4 ;  Bach & Hirschhorn, 1 9 6 4 ; Bach, Bach, & Joo , 1969) 
revealed th a t  a hyper-proliferative response  is produced w hen tw o  
populations of lym phocytes  with different HLA c lass  II an tigens are mixed. 
The phenom ena  w a s  te rm ed  a mixed lym phocyte  response  (MLR). Mitogen 
stimulation is an a s sa y  th a t  te s t s  T-cell function. It is a m ethod for th e  
polyclonal activation of T-lym phocytes (ASHI, 1 9 8 9 ,  p. 91).
P rocedure . V enous blood sam ples from fem ale  participants, their male 
sp o u ses ,  and unrelated controls w ere  collected by th e  Naval Hospital s ta f f  
using vacu ta iner tu b e s  containing th e  en richm ent media Acid Citrate 
Dextrose solution A (Vacutainer). Upon receipt, th e  tu b es  w ere directly
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centrifuged a t  7Q0xg (Intl. Equip. Co.) for 10 m inutes. Plasma from female 
participants and  their sp o u se s  w a s  sterilized through a 0 .2  //m filter 
(Schleicher and Schnell). Plasma from unrelated male contro ls  w a s  pooled 
in equal am o u n ts  and  filter sterilized.
The buffy c o a t  from each  sam ple w a s  collected into a sterile 50  ml 
conical tube  (Costar) using a sterile Pasteur pipette. Ten milliliters (10 mis) 
of the  buffy c o a t  w a s  loaded on to  a Ficoll-Hypaque separation  column 
com posed  of H istopaque 1 1 1 9  (5 mis) and  Histopaque 1 0 7 7  (5 mis) (Sigma) 
and spun  for 3 0  m inutes a t  7 0 0 x g .  M ononuclear cells w ere  collected using 
a sterile Pasteur p ipette  and  placed in a clean sterile 5 0  ml culture tube . The 
cells w ere  w a sh e d  once  w ith  5 0  mis of RPMI 1 6 4 0  media (Gibco) buffered 
with HEPES and containing 2  mM L-Glutamine, 1 00  units of penicillin/ml, 
100  //g/ml of s trep tom ycin , 0 .2 5  //g amphotericin/ml, 5 0  >c/g of 
gentamicin/ml (Sigma), and  com plem ented  with 2 0 %  AB heat-inactivated 
human serum  (Pelfreez). All media s tored  longer than  thirty days  w ithout 
use  w a s  replenished with 2 mM L-Glutamine (Gibco).
The cell su sp en s io n s  w ere  then  centrifuged a t  7 0 0 x g  for 10 minutes 
and the  su p e rn a ta n t  d iscarded . The cells were re -suspended  in 10 mis of 
RPMI media containing th e  commercial serum . A cell c o u n t  w a s  performed 
using a h em o cy to m ete r  (Baxter) with Trypan Blue (Sigma) and the  cell 
concentra tion  w a s  ad justed  to  1 x 1 0 6 viable cells/ml. S tim ulator cells w ere
4 9
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produced by incubating 5 mis of th e  adjusted cell suspension  with 0 .5  
mg/ml mitomycin-C (Sigma) for 3 0  minutes a t  room tem pera tu re . The cells 
w ere  then  w ashed  tw ice  with 5 0  mis of media to  remove residual 
Mitomycin-C. Microtiter round-bottom  plates (Costar) w ere  filled with 50  
//Is of responder cells and 5 0  //Is of non-proliferating (mitomycin-treated) 
stimulator cells in triplicates according to the  diagram in Figure 5. The 
culture system  w a s  incubated  in 5 %  C 0 2 at 37°C for sev en  days. On day 
four 5 0  //Is of PHA (Gibco) w ere  added  to the  designa ted  row. On day six 
2 0  //Is of 5 0  uCi/ml H3-thymidine (NEN Research Products) w a s  added  to  all 
wells. On day seven  th e  cells w ere  harvested  with a cell harvester 
(Cambridge technologies  Inc.) on to  fiber g lass  p ap er  (Cambridge 
Technologies Inc.). The cells w ere  bathed with distilled w a te r  which caused  
their lyses due to  its low osmolality. The released DNA with the  
incorporated radioactive iso tope w a s  trapped on the  fiber g lass  paper. The 
rinse and aspiration procedure w a s  repeated five tim es. The fiber g lass tab s  
containing the  cellular DNA w ere  then  transferred to  scintillation counting 
vials (Wheaton Scientific). Three milliliters of counting so lven t (Research 
Products  Intl. Corp.) w ere  added  to  each  vial. The vials w e re  coun ted  using 
a scintillation counter (Beckman). Data w as  en tered  into a Lotus 1-2-3 
(Lotus Corp.) spread sh e e t  (Appendix B).
5 0
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Rx bx UCIx UC2x PHA MEDIA
R 6 0 6  0 0 6  6 0 6  0 0 6  6 5 ) 0 0 6
S 0
UC1 0 Ce 11 types
0
R=Fema1e
UC2 S=Male spouseUC=Unre1ated male controls
PHA 0
x=Mi tomyc i n-treated 
st imulators
MED A 0
: iqure 5 . Mixed lym phocyte culture plate arrangem ent.
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To te s t  for plasma effec ts , four identical plates w ere  included fo r  each  
subject. The first plate contained  no plasm a. The second  plate had pooled 
p lasm a from unrelated male donors  to  serve a s  a control for the  general 
e f fec ts  of plasm a, including f re sh n ess .  A utologous plasma from th e  female 
sub jec ts  w ere  added back to  their MLC in the  third plate. The fourth  plate 
w a s  a cross-m atch  plate in which p lasm a from ectopic pregnant fem ales  
w a s  added  to  MLC's from normal an d  non-pregnant fem ales. Alternatively, 
MLC's from ectopic pregnant fem ales  received plasma from normal p regnan t 
fem ales.
Media Quality Control. Each ba tch  of  com plete  media (RPMI +  
Antibiotics +  Heat-inactivated AB serum ) w a s  te s ted  fo r contam ination. The 
media w a s  visually inspected  for turbidity, gram stained and cultured in 
sh eep  blood and  M acConkey ag ar  (BBL). Another s e t  of cu ltu res  w a s  
perform ed on cell suspensions  immediately before they  w ere transferred  to  
microtiter plates. In addition, a sam ple  from each  lymphocyte suspension  
w a s  cultured in PPOL broth over-night, transferred to  PPOL agar (Remel), 
and then  incubated along with th e  corresponding MLC for seven  days.
Any contam ination p resen t during or a t  the  end  of the  sev en  days  
resulted in th e  deletion of the  MLC from th e  s tudy . A total of 12 MLC's 
w ere  rejected based  on th e se  quality control criteria.
5 2
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Anti-paternal Lvmphocvtotoxicitv
Objective. The objective of th is  experim ent w a s  to  determ ine the  
p resence  or a b sen ce  of maternal anti-paternal lymphocytotoxic antibodies 
in the  p lasm a of fem ales with ectopic  pregnancy.
Background and  principle. The lymphocytotoxicity te s t  is routinely 
used  for HLA-A,B,C and DR antigen typing. The first m ethod w a s  
miniaturized by Terasaki (1964) . The National Institutes of Health 
s tandardized  the  procedure, while A m os (1965) modified th e  procedure and 
added  a w a sh  s tep  to  the  cell-serum wells a fter incubation. The w ash  s tep  
is n e cessa ry  to  remove non-specific com plem ent-activating com ponen ts .  
The principle of th e  te s t  is to  d e te c t  maternal com plem ent-dependen t 
cytotoxic antibodies against paternal lym phocytes through lym phocyte lysis.
P rocedure . One microliter of th e  adjusted lym phocyte suspension  
(1 x 1 0 6 cell/ml) from the  male sp o u se ,  male controls, and  fem ales w a s  
obtained from initial separation s tep  in th e  mixed lym phocyte culture a s sa y  
and transferred  to  a Terasaki microtiter plate (Robbins Scientific) with wells 
containing 1 //L light oil (Sigma). T h e se  cells w ere  then  incubated for 3 0  
m inutes a t  room tem perature  with p lasm a from the  fem ale spouse . Tw o 
negative control wells w ere  included, one  with the  lym phocytes of the  
female and her ow n  plasma and a n o th e r  with fem ale lym phocytes and 
com plem ent. A positive control well w a s  set-up containing female cells, a
5 3
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commercially prepared anti-lym phocyte an tibody (Pelfreez) and com plem ent. 
The plate a rrangem ent is show n  in Figure 6 . All th e  wells w ere  w ash ed  
three  tim es with phosphate-buffered  saline (PBS). Five microliters of freshly 
th aw ed  rabbit com plem ent (Pelfreez) w a s  added  to  each  well. After the  
w ash , the  system  w a s  incubated for 1 hour a t  room tem pera ture . Filtered 
5%  aqueous  Eosin Y (Sigma) w a s  added  to each  well and incubated for 3-5 
minutes a t  room tem perature . Five microliters of buffered form aldehyde 
(pH =  6 .8 -7 .5 )  w ere  added  a t  the  end  of the  incubation period. A cover slip 
w a s  placed over the  entire plate and th e  cells w ere  allowed to sett le  for 15 
minutes before reading. Each well w a s  read under an inverted phase  
microscope (American Optics) a t  150 x . Dead cells lysed by the  action of 
antibodies in maternal serum  or the  positive control appeared  dark, diffused, 
granular, and non-reflectiie.
5 4
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R S UC1 UC2 POS NEG
U/ D OO CO OO OO OO OO
1:2 O C e ! I t y p e s
1 : 4  O R=FemaIe
S=Male spouse
UC=UnreIated male c o n t r o l
: ioure 6 . Anti-paternal lymphocytotoxic a s sa y  plate arrangem ent. The row s
represen ted  maternal plasma (un-diluted, 1:2 and 1:4  dilutions).
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The unaffected ceils looked shiny and their m em brane  integrity w a s  round 
and reflectile. The reactions were rated a s  follows (ASHI, 1989 , p. 199):
Score % Cell Death Interpretation
1 0  - 10 Negative
2 1 1 - 2 0 Borderline negative
4 21 - 50 W eak positive
6 51 - 80 Positive
8 81 - 100 Strong positive
0 Unreadable None
Peripheral Blood Leukocyte Phenotvpinq bv Flow Cvtom etrv
Objective. The objective of this experim ent w a s  to  determ ine w h e th e r  
any  of th e  three conditions had a different num ber of circulating leukocyte 
pheno types .
Background and principle. Flow-cytom etry is a cell sorting m ethod in 
w hich fluorescent monoclonal antibodies to  certain cell markers are used to  
identify the  different leukocyte pheno types  in peripheral blood. The m ethod 
is capab le  of measuring and  differentiating cells based  on size, shape , 
cytoplasm ic granularity, pigm ent con ten t ,  DNA/RNA c o n ten t ,  and chromatin 
sh ap e .  The sample is a cell suspension  th a t  is s ta ined  with
56
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fluo rescen t conjugated an tibodies. Light and photomultipliers are then  used  
to  identify s tructure  and staining p a t te rn s  (ASHI, 1 9 8 8 ,  p. 238).
P rocedure . Blood sam ples  w ere  s e n t  to  W alter Reed Medical C enter 
and  s to red  a t  room tem pera tu re  until processing. Whole blood w a s  s tained 
by the  direct method separa te ly  with each  fluorochrome labeled monoclonal 
antibody (fluorescein iso th iocyana te  or phycoerythrin) (Becton-Dickinson). 
Fifty micro-liters of blood, 5 0  fj\ of p h o sp h a te  buffered saline (PBS), and  10 
//I of each  ty p e  of conjugated an tibody w ere  mixed in a 1 2m m  x 7 5 m m  tube  
(Falcon) and  incubated a t  4°C for 15 m inutes in the  dark. Appropriate 
iso type negative controls (w ithout th e  conjugated  antibodies) w ere  included 
with each  patient sample.
The stained cells w ere  w a sh e d  w ith 3 .5  ml of PBS containing 0 .0 1 %  
sodium azide and centrifuged for th ree  m inutes a t  1 5 0 0  rpm (Beckman). All 
bu t 50  //I of th e  superna tan t w a s  discarded . The red blood cells w ere  lysed 
in th e  remaining cell pellet. A fter the  last w ash  following lysis the remaining 
cells w ere  resuspended  with 1 %  paraform aldehyde in PBS and analyzed by 
flow -cytom etry  (Facstar Plus Cell Sorter  or the  Coulter Epics Elite Cell 
Sorter). The results w ere  ex p re ssed  a s  a ratio of the  total leukocyte 
population th a t  the  flow cy to m e te r  g a ted  fo r analysis.
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Data Manipulation and Statistical Analysis 
Mixed Lymphocyte Cultures
The MLC and PHA experim ents  produced interval da ta . The basic unit 
of m easu rem en t for th e  MLC w a s  coun ts  per minute (CPM) read by the  
scintillation counter. T he  co u n ts  w ere  transferred to  a Lotus 1-2-3 spread 
sh ee t .  The spread  s h e e t  w a s  construc ted  to  allow m athem atical 
manipulation of the  CPM in acco rdance  with the  guidelines s e t  by the  
American Society of Histocompatibility and  Im m unogenetics Laboratory 
Manual (1989). The first manipulation te rm ed  th e  Stimulation Index (SI) 
w a s  a  proportional represen ta tion  of CPM from each  mixed lym phocyte  
culture to  the  CPM from th e  au to logous culture. It w a s  calculated according 
to  th e  formula: RSx (or RUCx) /  RRx; w here  R is the  viable female 
responding cell, Rx, Sx, UCx are the  m itomycin-treated fem ale, male spouse , 
and  male control cells, respectively. Both RSx and RUCx rep resen t CPM 
from a mixed culture w h e rea s  RRx represen t CPM from an au to logous 
culture of female cells responding to  an identical population of mitomycin- 
trea ted  cells from the  sam e  female. A utologous cultures w ere  designa ted  
as  the  background or baseline against which each  mixed lym phocyte  culture 
w a s  te s ted  to produce th e  SI. The unrelated control stimulation index w a s  
calculated  by averaging th e  th ree  S i 's  produced by the  fem ale to  e ac h  of the  
th ree  controls. Mathematically, the  control MLC's w ere  calculated  a s
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follows: (RUCx 1/RRx +  RUCx2/RRX +  RUCx3/RRX) /  3; w here  RUCx 1/RRx 
is the  SI of the  fem ale to  the  first unrelated control and so  forth.
A different manipulation of th e  sam e  CPM from the  sam e  MLC data 
produced the  percen t response  rate  (%RR). Response ra tes  represent the 
rate a female responds  to  her husband  relative to the  controls. Hence, a 
1 0 0 %  RR m eans  th a t  th e  response  of th e  female to her husband  is equal to 
her response  to  th e  controls. R esponse  ra tes  higher than  1 0 0 %  indicate a 
g rea ter  female response  to  her husband  than  to  controls (ASHI, 1989). The 
m athem atical representation of this ra te  is:
{ RSx - RRx /  [(RUCxI +RU Cx2 +  RUCx3/3)] - RRx } * 1 00  
Mitogen Stimulation Data
The PHA simulation experim ent is a standard  a ssa y  for determining 
th e  non-specific, polyclonal activation o f  T-cells (Jha e t  al., 1974). PHA is 
also used a s  a control to  d em onstra te  th a t  mitomycin-treated cells are 
incapable of proliferating. The m ethod of simulation differs from the MLC 
since a plant-derived mitogen is used to  elicit a lymphocyte response. The 
te s t  culture consis ted  of mitogen plus th e  responding viable cells, while the  
control cultures w ere  th e  viable cells in media alone.
Lvmphocvtotoxicitv Data
Lymphocytotoxicity data is determ ined by measuring cell death . It is 
ordinal in nature. The positive and  negative controls w ere  a s s e s s e d  first to
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determ ine the  su cc e ss  o f  the  a ssay  and patient readings followed. 
Lymphocytotoxicity w a s  determ ined after th e  addition of maternal plasma 
to  male spouse , male control, and auto logous cells.
Leukocyte Phenotypes
Data from this a s sa y  produced  a ratio for each  pheno type  to the  total 
lym phocytes ga ted  for counting . An average  of each  phenotype  w a s  
calculated and a one-w ay  analysis of variance w a s  performed to  d e tec t  any  
differences in the  distribution of pheno types  am ong the  pregnancy 
conditions.
Statistical Analysis 
All statistical ana ly ses  w ere  performed using SYSTAT softw are  
(SYSTAT Inc.) The sampling p rocess  and  sam ple size violated th e  basic 
requirem ents for inferential s ta tis tics . Since the  sample w a s  no t randomly 
selec ted  a Bartlett Chi-square te s t  for the  hom ogeneity  of group variances 
w as  perform ed and th e  hypo thesis  of no hom ogeneity  of group variances 
w as  rejected ( p < 0 .05).  T he  te s t  indicated th a t  the  sam ples w ere  a t  least 
drawn from hom ogeneous  populations with respect to  their variances 
(Daniel, 1987). All the  param etric  statistical procedures w ere  used to 
describe the  sample under investigation and  not to provide population 
inferences.
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H,: There is no difference in the  m ean %RR of fem ale  or male 
lym phocytes am ong th e  th ree  conditions . Mean %RR obtained  from the 
MLC a ssa y  w ere  analyzed  using a factorial model analysis of variance 
(ANOVA) followed by a o n e -w ay  (ANOVA). Basic s tatistics  w ere  calculated 
for %RR including m e an s  and s tandard  errors a b o u t the  m ean. The female 
responses  to  her male sp o u se  cells w ere  analyzed followed by th e  re sp o n ses  
of the  male sp o u se  to  th e  lym phocytes  of his female spouse .
H0: There is no difference in the  m ean SI of female MLR's am ong the  
three pregnancy conditions, tw o  stimulating cell types , and  five plasma 
types.
The da ta  w a s  categorized  into th ree  independent variables: pregnancy  
condition, plasma type , and  stimulating cell type  for the  factorial design. 
Following tha t ,  th e  various tre a tm e n ts  w ere  te s te d  using a one-w ay  analysis 
of variance. The ANOVA w a s  s e t  to  exclude any  unequal cells. T ukey 's  
honestly significant d ifference (HSD) for multiple com parison of m ean s  w as  
performed to  t e s t  for the  null hypothesis  th a t  all th e  m eans  p roduced  by the  
trea tm en t w ere  equal. T he  sam e  statistical analyses  w ere  carried o u t  using 
the  %RR as  a d ep en d en t variable.
H0: There is no difference in th e  m ean SI of male-to-male MLR's 
am ong th e  five plasm a ty p e s .
The e ffec ts  of p lasm a w ere  also a s s e s s e d  using th e  previous
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statistical techn iques  on the  S i 's  of unrelated male controls stim ulated with 
male lym phocytes.
I-L: There is no difference in th e  m ean SI of PHA stimulation of 
fem ale  lym phocytes am ong th e  th ree  p regnancy  conditions and five plasma 
ty p e s . Data from the  re sp o n ses  of fem ale lym phocytes to  PHA w as  
analyzed using a one-w ay  ANOVA to  t e s t  th e  e ffec t  of pregnancy  condition 
and plasma type  on PHA stimulation index.
H„: There is no difference in m aternal cytotoxic activity against 
paternal lymphocytic an tigens  am ong  th e  th ree  pregnancy conditions. Data 
from this a s sa y  consis ted  of ratings of each  microscopic field. The maternal 
lym phocytotoxic activity w a s  g rouped by condition. O ther than  th e  positive 
control, none of the  t re a tm e n ts  sh o w e d  evidence of any cell dea th  or 
lymphocytotoxicity. Since all of th e  experim ents  yielded the  sam e  rating of 
" 1 1 o r "negative" for cell dea th , no s tatistical analysis w as  necessa ry .
H„: There is no difference in th e  pheno types  ratio am ong  the  th ree  
p regnancy  conditions. Phenotyping ratios w ere  averaged  for each  ty p e  and 
analyzed using a one-w ay  ANOVA to  determ ine if there  is any  difference in 
th e  pools of circulating lym phocytes  in each  of the  th ree  p regnancy  
conditions.
62
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
CHAPTER FOUR 
Results
Analysis of statistical ou tp u t 
The factorial model ANOVA using the  SI a s  the  dependen t variable 
indicated th a t  "pregnancy condition" is a statistically non-significant 
e stim ate  of the  SI (F= 2 .5 0 3  and p  =  0 .0 8 ) .  Hence, "pregnancy condition" 
alone can n o t  explain the  variability in lym phocyte  responses. "Stimulating 
cell type" show ed  significance {F= 4 .321  and p  = 0 .04 ).  The m ean SI 
produced by stimulation with unrelated male control cells (M =  1 4 .6 2 9  ±  
S.E.M =  1 .997) w a s  significantly higher than  th a t  produced by male sp o u se  
cells (9 .5 5 3  ±  1 .587). However, th e  difference be tw een  sp o u ses  and 
controls a s  stimulators w a s  only ev iden t in the  non-pregnant group 
{F= 8 .721  and p  =  0 .003 )  indicating th a t  fem ales  in this group responded 
g rea ter  to  unrelated male controls  th an  to  their spouses . Normal and 
ectopic p regnant fem ales show ed  similar re sp o n ses  to  their sp o u se s  and 
controls.
The s tro n g es t  significance w a s  obtained w hen  "plasma type" w a s  
en tered  a s  the  only variable in th e  model (F= 3 .541  and p  = 0 .0 0 8 ) .  
Hypothesis testing  of the five types  of plasma revealed th a t  au to logous 
plasma produced a significantly g rea te r  m ean  SI than  any other type. This 
finding, how ever, limited the  analysis, since auto logous plasma could be
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further divided into th ree  ty p es  depending on the  pregnancy  condition of the  
female donor. Therefore, a one-w ay  analysis of variance followed th e  fac to r  
analysis model. The sam e fa c to r  model ANOVA w a s  also performed using 
the  %RR to  represen t MLR a s  the  dependen t variable. The results failed to 
sh o w  any significance regardless of the  num ber of fac to rs  in the  estimation 
model.
The one-w ay  ANOVA produced 2 4  m eans  for each  SI (Table 1) and 
%RR representing a!! the  possible com binations of the  independent 
variables. Each of the  2 4  unique cultures w a s  trea ted  a s  an independent 
t rea tm en t and  the  one-w ay  ANOVA along with T ukey 's  Honestly Significant 
Difference (HSD) w a s  perform ed. PHA da ta  and  leukocyte pheno types  da ta  
w ere  analyzed using th e  sam e  m ethods.
Interpretation of results 
The addition of plasma from normal p regnan t fem ales produced 
significant en h an c e m en t  from autologous MLC {p < 0 .0 0 1 ) .  This increase 
w a s  seen  w h en  both the  male spouse  cells (Figure 7) and the  male unrelated 
control cells (Figure 8) w ere  used a s  stimulators. MLC's from ectopic and 
non-pregnant fem ales w ere  no t enhanced  by their au to logous plasma. In 
addition, plasm a from ectopic pregnant fem ales  failed to  en h an ce  MLC's 
from normal p regnan t fem ales. Collectively, th e se  d a ta  point to  an
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Stimulation Index M eans (and S.E.M) for each  T rea tm en t
Plasma type
None Pooled male Autologous Pregnant lictopic pregnant
Pregnancy Stimulating
condition cell tvnc
Non-pregnant Spouse 7.43(2.63) 5.45(1.54) 3.99(1.03) N /A 1 6.28(0.99)
Control 12.07(3.13) 12.79(4.29) 12.57(4.67) N/A 18.14(6.06)
Normal Spouse 8.40(2.00) 4.46(1.41) 33.38(16.07) N/A 2.71(0.78)
Control 8.51(2.13) 5.65(1.37) 45.98(18.94) N/A 3.97(1.18)
lictopic Spouse 8.64(2.23) 10.94(3.02) 12.07(2.96) 2.61(0.79) N /A J
Control 11.30(2.31) 11.96(2.65) 16.36(4.38) 6.48(2.35) N/A
1 Plasma from normal p reg n an t  fem ales w a s  no t added  to  MLC's from non-pregnant or o ther p regnan t 
fem ales.
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enhancing  capability in plasma from pregnant fem ales th a t  is lacking in 
ectopic p regnan t and non-pregnant fem ales.
Moreover, enhancem en t w a s  no t seen  w hen  normal p regnant plasma 
w as  added  to  MLC's from ectopic  p regnant fem ales indicating tha t  
lym phocytes from ectopic fem ales  are incapable of responding to  this 
enhancing  factor(s). Thus, th e  first tr im ester of a normal pregnancy is 
characterized by tw o  changes: a) th e  p resence  of soluble plasma fac tors  
and b) lym phocytes tha t are responsive  to  th e se  factor(s). Both of these  
phenom ena  are lacking in ectopic  gesta tion . Paradoxically, w hen plasma 
e ffec ts  w ere  te s te d  on male-to-male MLC's, cultures with no plasma had a 
significantly higher SI than all the  cu ltu res  with plasma [p<  0 .0 5 ) .  Plasma 
sh o w ed  a universal depression of stimulation regardless of its type  (Figure 
9).
Cultures with no plasma produced  similar results in the  MLC across  
all p regnancy  conditions and w ith th e  tw o  ty p es  of stimulator cells. The 
addition of pooled male plasma to all th e  cultures produced no significant 
differences am ong the  three p regnancy  conditions and plasm a types .
R esponse  ra tes  from cultures with no plasma w ere used  to  com pare 
the  re sp o n ses  of fem ales to  stimulation with their male sp o u se s  relative to 
unrelated male controls. R esponse  ra tes  w ere  also used  to  com pare  th e  
re sp o n ses  of the  males to stimulation with their female sp o u se s  relative to
68
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unrelated male controls (Figure 10). With a 1 0 0 %  indicating an identical 
response  of th e  te s ted  group relative to  controls , fem ales  sh o w ed  a 
reduced , bu t no t significant, response  (9 1 .0 9 2  ±  1 0 .7 6 1 )  to their husbands  
relative to  contro ls  over all pregnancy conditions. No significant difference 
w a s  en coun te red  w hen  response  ra tes  w ere  com pared  am ong th e  three 
p regnancy  conditions. A te s t  of fem ales  a s  s tim ulators of their husbands  
lym phocytes  relative to  male controls also revealed no significant difference 
am ong the  th ree  conditions. None of the  fem ale  lym phocytes  w ere  be tte r  
a t  stimulating their h u sb an d s  lym phocytes.
Analysis o f  PHA t rea tm en t revealed a significantly higher stimulation 
index {F= 2 .4 3 9  a n d p  < 0 .0 0 1 )  in all cu ltu res  w ith  no plasm a. This increase 
w a s  s e e n  in all p regnancy  conditions (Figure 11). T here  w a s  no  difference 
in the  response  of lym phocytes from th e  various p regnancy  conditions to  
PHA stimulation. Both male and fem ale cells responded  in a similar fashion 
to  PHA. As in th e  male-to-male MLC's, PHA cultu res  w ere  significantly 
inhibited with th e  addition of any  type  of p lasm a.
The anti-paternal lymphocytotoxic a s s a y  yielded a negative reading on 
all t e s t  wells. T hus, the  rating of "one" w a s  a ss igned  to  each  experim ent 
and no statistical analysis w a s  deem ed n ecessa ry  in lieu o f  th e  uniformity 
of the  results. T he  positive and negative controls in th e  a s s a y  consisten tly  
performed a s  ex p ec ted .  Plasma from normal p regnant, ectopic  p regnant,
7 0
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and non-pregnant fem ales  w a s  marked by the ab sen ce  of com plem ent- 
d epen d en t cytotoxic antibodies. This da ta  supported  the  conclusion of 
previous s tud ies  (Regan & B raude,1987 ; H asegaw a, 1990) in which the  
p resence  of anti-paternal lym phocytotoxic antibodies w a s  not a lw ays 
necessa ry  for the  m ain tenance  o f  normal pregnancy.
The analysis of th e  peripheral blood leukocyte pheno types  (Figure 12) 
yielded no significant d ifferences {p > 0 .0 5 ) .  The pe rcen tages  of circulating 
pheno types  w ere  similar in th e  th ree  pregnancy conditions.
Sum m ary  of results 
The couples in the  s tudy  w ere  te s ted  for immunogenetic hom ogeneity  
using MLC response  ra tes. There w a s  no statistical difference be tw een  the  
%RR am ong the  female g roups indicating th a t  lymphocytes from all couples 
functioned equally well a s  simulators or responders. Furthermore, there  
w ere  no shifts in peripheral blood leukocyte phenotypes  am ong the  three  
pregnancy  conditions.
MLC's with male lym phocytes a s  stimulators w ere  used to  
characterize maternal immunity within th e  first tr im ester of pregnancy . 
Lymphocyte proliferation of non-pregnan t fem ales to  their male sp o u se s  
lym phocytes w a s  significantly lower com pared  to unrelated m en. However, 
this difference w a s  no t observed during normal and ectopic pregnancy.
73
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Female participants w ere  a lso  te s ted  for immunoregulatory plasma 
fac tors . The addition of au to logous  plasm a significantly enhanced  MLC's 
from fem ales with normal p regnancies  w hen  either sp o u se  or unrelated male 
lym phocytes w ere  used  a s  stim ulators. The  sam e  plasma did not enhance  
lym phocyte  re sp o n ses  of fem ales  with ectopic  pregnancy, suggesting  tha t 
th e  augm entation  is specific to  cells from normal p regnan t fem ales. In 
co n tra s t  plasm a from males, ectop ic  fem ales  and non-pregnant fem ales  did 
no t contain any  enhancing fac to rs .  Unrelated male-to-male MLC's were  
significantly inhibited by all ty p e s  o f  plasm a.
Female participants w ere  also  te s ted  for th e  e ffec ts  of plasm a fac to rs  
on PHA-stimulated cultures. All lym phocyte  cultures  proliferated over the  
baseline culture with th e  addition of the  m itogen. However, the re  w ere  no 
differences am ong th e  th ree  p regnancy  conditions. The addition of plasma 
regardless of source  produced significant inhibition of PHA re sp o n ses .  The 
general inhibition seen  in PHA-stimulated cultures supports  previous findings 
th a t  implicated plasma « 1  - Anti-trypsin (Breit, 1982). T hus, the  enhancing 
capabilities of plasma from normal p regnan t fem ales w a s  restricted to 
allogeneic stimulation.
7 5
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CHAPTER FIVE 
Sum m ary, Discussion, and Conclusions
The results of th e  MLC a s s a y  w ithout the  addition of plasma 
sugges ted  th a t  there  are no d ifferences in the  responses  of fem ales to  their 
spouses  a s  com pared  to  o ther  male controls am ong the th ree  pregnancy 
conditions. Thus, HLA differences or similarities be tw een  mating couples 
a s  m easured  by the  MLC w ere  no t a predeterm inant of either ectopic  or 
normal pregnancy. The results  did not indicate an immunogenetic 
predisposition to  ectopic  gesta tion .
Plasma from normal p regnan t fem ales  has  factor(s) th a t  en h an ced  the 
response of au to logous lym phocytes. This factor(s) w a s  lacking in the 
plasma of ectopic p regnan t and  non-pregnant fem ales.
Moreover, there  w a s  a cellular co m ponen t to th e  increased response  
encountered  in th e  cu ltures  of p regnan t w om en. Plasma augm enta tion  of 
lymphocyte re sp o n ses  from normal p regnant fem ales canno t be a ttributed 
to the plasma type  alone. If th e  factor(s) found in plasma of p regnant 
w om en is a non-specific source  of en h an cem en t,  then  it is ex p ec ted  th a t  all 
MLC's will respond to  th e  addition of plasma from normal p regnant w om en . 
However, this w a s  not th e  case .  The addition of plasma from normal 
pregnant fem ales did not en h an ce  th e  MLC's of ectopic fem ales and  male
7 6
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MLC's. Therefore, there  are cellular changes  th a t  m u s t  accom pany  the 
soluble (plasma) a ttr ibu tes  in order to  stimulate lym phocyte  responses. 
Hence, lym phocytes from pregnant fem ales contain  a specific mechanism 
th a t  is capable  of responding to  this factor(s) in th e  p regnan t plasma. The 
m echanism of e n h an cem en t m ay be in the  form of cell m em brane receptors 
or o ther forms of cellular recognition th a t  bring a b o u t the  increased 
lym phocytes responsiveness .
Mixed lym phocyte re sp o n ses  from ectopic p regnan t w om en  exhibited 
unique characteris tics  d istinguishable from normal p regnan t fem ales. Unlike 
MLC's from pregnant w o m en , lym phocytes from ectop ic  p regnant females 
were not responsive to  th e  addition of au to logous or normal pregnant 
plasma. Even though gesta tional age and parity of th e  normal and ectopic 
pregnant fem ales w ere  com parable , lym phocytes from normai pregnancy 
seem  to  respond vigorously in th e  presence  of their ow n  (autologous) 
plasma. Plasma from ectop ic  p regnant fem ales lack th e  enhancing soluble 
factor(s) p resen t in the  p lasm a of normal p regnan t fem ales  and their 
lym phocytes lack th e  cellular elem ents  necessa ry  fo r responding to  this 
factor(s).
Further support for the  involvement of a cellular co m ponen t in the 
observed en h an cem en t is th a t  th e  sam e plasma ty p es  did no t exhibit similar 
e ffects  on unrelated male mixed lymphocyte cultures. On th e  contrary, the
7 7
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addition of any  plasm a, regardless of ty p e ,  sh o w ed  a general inhibitory 
e ffect . The lack of en h an cem en t in male-to-male MLC's point to  the  
p resence  of a specific m echanism  by w hich  lym phocytes from normal 
p regnan t fem ales  respond to  the  putative soluble factor(s).
Allogeneic stimulation in MLC is a p roduc t of difference in th e  class  
II HLA b e tw een  maternal and paternal lym phocytes. The addition of p lasma 
form pregnant fem ales en h an ces  th e se  allogeneic responses. W hat, then , 
is responsible fo r the  en h an cem en t of MLR th a t  is seen  in th e  MLC's of 
normal p regnant fem ales bu t not in ectopic o r  non-pregnant fem ales?  One 
of th e  major differences be tw een  normal p regnancy  and  ectopic p regnancy  
is th e  secre to ry  dynam ics of som e pregnancy  horm ones. P rogesterone 
levels are lower in ectopic pregnancy than  in normal pregnancy (Stovall e t  
al., 1 9 8 9 ) .  Progesterone is known to  up-regulate estrogen  receptors  (Sitteri, 
Febres, Clemens, Chong, Gondes, & S t i te s ,1 9 7 7 ;  Clemens, Sitteri, & S ti tes ,  
1979), and th e se  receptors  have been found on T-lymphocytes (Paavonen, 
A nderson, & Adlercreuts, 1981; Feigen, Fraser, Peterson, & Dandlikes, 
1978). Therefore, in normal pregnancy progesterone  may up-regulate 
es trogen  receptors  on T-cells, and the  addition of autologous plasm a rich 
with es trogen  may result in T-cell proliferation through the direct action of 
es trogen . Estrogen is also known to  inhibit su p p resso r  activity th u s  adding 
more to  hyperactivity of T-cells. Since ectopic  pregnancy has  lower levels
78
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of both p rogesterone and e s tro g en  then  th is  interaction b e tw ee n  the  
immune and  endocrine sy s tem  is lacking and  T-cell en h an c e m en t  m ay not 
proceed  a s  efficiently. Furthermore, male lym phocytes are not under the  
e ffec t  of progesterone  and m ay no t have  th e  estrogen recep tors . Hence, 
male lym phocytes  may not be responsive  to  th e  addition of e s trogen  th a t  is 
found in th e  plasma of normal p regnan t fem ales . Accordingly, the  p roposed  
model m ay explain the  lack of male responsiveness  to plasma from pregnan t 
fem ales  th a t  w a s  dem onstra ted  in this  s tudy.
Kasakura (1971) sh o w ed  th a t  fetal plasma a s  well a s  p regnan t 
plasm a are inhibitory to mother-child MLC, while unrelated MLC w ere  
inhibited by pregnancy plasma only. This w ork  along with Bissenden e t .  al. 
(1980) referred to  an inhibiting fac to r  or an tibody th a t  m ay be produced 
early in p regnancy. Most sub jec ts  in th e se  earlier s tudies w ere  g rea te r  than 
12 w e e k s  gestational age. This evaluation of immune function in ectopic  
p regnancy  presen ted  data  regarding th e  behavior of p regnan t plasm a early 
in th e  first trim ester. Prior s tud ies  report a significant increase  in inhibition 
a s  p regnancy  progresses (McIntyre e t  al., 1 9 7 9 a ;  1979b; Bissenden e t  al., 
1 9 8 0 ;  Herva e t al., 1977). The results  of immunologic da ta  in ectopic 
p regnancy  p resen ted  in this  paper  along with the  findings from previous 
research  indicate tha t  a t early s ta g e s  of p regnancy  there  is an increase  in 
immune recognition th a t  is then  dow n-regula ted  a s  pregnancy  p rogresses .
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This paper  sh o w ed  th a t  early normal pregnancy  is characterized by 
hyperactive allogeneic lym phocyte responses  th a t  are  subsequen tly  dow n 
regulated. The dynam ic progression of maternal immunity from hyper- to  
hypo-activity and th e  balance b e tw een  en h an cem en t and  inhibition seem  to 
be important in su ccess fu l  pregnancy. This proposed balanced  seem s to  be 
regulated by soluble p lasm a factor(s) and cellular modifications in effector 
cell populations. The production of irCG in MLC m ay hold one explanation 
for this bimodal e ffec t .  At low levels irCG is capable  of enhancing  MLR, but 
a s  its concen tra tion  increases, it sh o w s  a suppress ive  e ffec t  on MLR 
(Harbour-McMenamin, Smith, & Blalock, 1986). Pregnancy can  be though t 
of as  one-w ay  MLC w here  th e  lym phocytes of th e  m other are responding to  
stimulation by fetal t issue . If the  production of irCG and  its e ffec ts  on 
maternal lym phocytes in vivo  are similar to  th o se  in vitro , then  it is possible 
th a t  the  e ffec ts  o f  irCG in vivo  prom ote e n h an cem en t in early pregnancy and 
later suppression  of immune responses . As a result, th e  immunology of 
pregnancy f luc tua te s  with the  progression of gesta tion . At early s tag es  of 
pregnancy, allogeneic d ifferences support recognition of the  fe tus. 
Recognition is needed  for th e  o n se t  of specific inhibitory e ffec ts  such  as  the  
humoral production of blocking antibodies which will later prevent the  
rejection and su b se q u e n t  destruction  of the  implanted fe tu s .
80
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The model for studying fe to-m aternal immunologic interactions in this 
s tudy  selec ted  paternal lym phocytes to  rep resen t fetal t issue  and  proceeded  
to investigate m aternal immune reactions to  th e se  paternal antigens. This 
in vitro  model m ay be used a s  a practical venue  to study in vivo  maternal 
immune re sp o n ses  to  the  implanted fe tu s  since it may be presum ed th a t  
maternal immune response  to  paternal an tigens  proximate responses  
produced by fetal an tigens. First, the  fe tu s  can  be regarded as  a sem i­
allograft since it ex p re sses  inherited paternal antigens no t found in th e  
mother. S econd , there  is ev idence  th a t  maternal immune reactions to  feta! 
tissue produce humoral and cellular specificities similar to  th o se  found on 
paternal t issue  (Horini, & Terasaki, 19 8 2 ; Reed, Bonagura, Kung, King, & 
Suciu-Foca, 1983). Both th e se  observations  render sufficient support for 
the  use of paternal t issue  in place of fetal t issue  to  s tudy  feto-m aternal 
immunobiology.
The u te rus  undergoes  various ch an g es  in normal pregnancy th a t  m ay 
be responsible for enhancing allogeneic activity in the  first trim ester. Based 
on data  p resen ted  in this s tudy , a probable m echanism would involve the  
appearance  of plasma factor(s) and appropriate m em brane recep tors  on 
lym phocytes. In ectopic  pregnancy , uterine c h an g es  occur proximal to  the  
implantation site, and  th e se  c h an g e s  are incomplete in com parison to  normal 
pregnancy (Cunningham e t al., 1989). The retardation of normal uterine
81
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developm ent in ectopic  gesta tion  m ay com prom ise its putative immuno- 
regulatory role and  reduce  alloreactivity. Moreover, in ectopic  gesta tion  the  
developm ent of th e  b lastocyst is impaired and it m ay p resen t different 
antigens than  normal trophoblast. Studies cited in th e  review of the 
literature em phasize  th e  major role HLA play in the  regulation of pregnancy. 
If the expression o f HLA is altered due  to the  com prom ised developm ent of 
the  ectopic  b lastocyst, then  the  ensuing MLC studies m ay  provide results 
distinguishable from normal pregnancy MLC's.
Lym phocyte s tud ies  in the  peripheral blood su g g e s t  th a t  m ost of the 
effector cell activity proximal to  th e  u terus is secondary  to  the  s u c c e ss  of 
implantation. Earl e t  al. (1987) and Maruyama e t  al. (1992) report 
d ifferences in the  effec tor  cell population be tw een  the  decidua of ectopic 
and normal p regnan t fem ales. The presence  of th e se  unique cell populations 
a t the site of ectop ic  implantation and the  signals th a t  p a ss  b e tw een  these  
cells and the  trophob las t may explain som e of th e  immunoregulatory 
differences b e tw een  normal and ectopic pregnancy no ted  in this study. 
Further s tudies  regarding th e  interaction be tw een  effec to r  cell populations 
and fetal e lem ents  m ay help characterize the  role the  imm une sy s tem  plays 
in maintaining a success fu l pregnancy.
Further s tud ies  may reinforce th e  results of the  curren t s tudy  by 
adding s te p s  to  th e  design th a t  solidify the  conclusions regarding th e  effect
8 2
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of p regnan t plasma. T he  inclusion of a culture in which normal p regnant 
plasma is added to  non-pregnant mixed lym phocyte cultures will help in 
ascertaining w h e th er  th e  e n h an c e m en t  is due to  acquired cellular 
responsiveness  in normal p regnancy  and w h e th e r  lym phocytes from ectopic 
p regnancy  mimic lym phocytes from non-pregnant fem ales  in their 
nonresponsiveness  to  p lasm a from  pregnan t fem ales . A more extensive 
characterization of p regnancy  horm ones  and their e ffec t on the  immune 
response  in early p regnancy  m ay  verify so m e  of th e  proposed interactions 
be tw een  the  immune and  endocrine sy s tem s . Additional information on the  
production of irCG m ay elucidate its role in the  survival of th e  fe tus . In 
general, fu ture  research is needed  to  characterize  th e  factor(s) p resum ed to 
be a t  w ork  in normal p regnan t p lasm a. The interaction of th e  various ty p es  
of e ffec to r  cells a t  th e  fe to-m aternal interface m us t be further defined. 
Moreover, there still remains the  role of cytokines in maternal 
immunomodification. With the  ad v en t  of new  technology it is becoming 
easie r to  m aster  th e  s tu d y  of cytokine molecules, their com plex e ffec ts  on 
pregnancy , and their in teractions with th e  endocrine sy s tem . All the  
previous proposed issues  will provide a g rea te r  understanding  of 
reproductive biology and how  its application may aid in th e  control of 
reproductive functions and  ou tco m es .
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In conclusion, results  from this s tu d y  indicated th a t  the re  is an 
en h an cem en t of re sp o n ses  in the  lym phocyte  responses  in p regnan t w o m en  
w hen  com plem ented  with their (autologous) plasm a. This phenom ena  w a s  
not seen  in MLC's from ectopic p regnan t fem ales and may be due  to  the  
p resence  of plasm a factor(s) in normal p regnan t fem ales in the  first tr im este r  
th a t  au g m en ts  lym phocyte  proliferation. In addition, there  is ev idence  th a t  
lym phocytes from  ectopic  fem ales  are incapable of responding to  this 
factor(s) in th e  sam e  m anner a s  lym phocytes  from pregnant fem ales . The 
s tudy  indicated th a t  m aternal immunologic responses  are altered in ectopic  
pregnancy. This m ay be directly related to  alterations in fe to-m aternal 
interactions and  fetal developm ent in the  uterine versus tubal environm ent. 
Further characterization of th e se  findings m ay provide g rea te r  know ledge 
regarding the  immunologic role o f th e  intrauterine environm ent in supporting 
normal p regnancies .
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APPENDIX A 
Determination of Cell Concentrations 
Objective
This experiment w as performed to determine the ratio of responder to 
stimulator cells to be used in each MLC assay.
Procedure
Lymphocytes were separated , cultured, and treated with Mitomycin-C in 
accordance with the protocol outlined in chapter three. A matrix se tup  outlined 
below included three responder and stimulator cell concentrations. The 
stimulation index (SI) w as  calculated using the formula listed in chap ter three. 
"R" represented the responding lymphocyte population, "Rx" represented the 
stimulator population in the autologous culture. Two unrelated controls (UC1 x, 
UC2x) w ere also used as stimulators in the  mixed lymphocyte cultures.
Result
There w as no significant difference in the SI obtained using 5x10 4 or 
10x10 4 stimulator-to-responder cell combinations per well. Using 20x 1 0 4 for 
either the responder or stimulator w as not feasible due to the large amount of 
blood that would be needed from each participant (Table B1). Therefore, the 
concentration used in this study was: 5x104 responder cells and 5x10 4 
stimulator cells per well.
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Table B1
Stimulation indices of various combinations of stimulator and responder cell 
concentrations per well
Responder cells per well
R 5x1 0 4 R IQxIO4
Stimulator cell 
per well
UC1x 5x10 4 19.91 19.83
UC1x 10x104 11.59 18.51
UC1x 20x10 4 80 .62  4 7 .3 4
UC2x 5x10 4 47 .78  32 .16
UC2x 10x104 24 .26  40 .30
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Determination of Mitogen Concentration 
Objective
The objective of the  experiment w as to  determine w hether 1 :100 or 
1 :200 dilution of PHA is more effective for maximum lymphocyte proliferation.
Procedure
Lymphocytes w ere separated , cultured, and treated with Mitomycin-C in 
accordance with the protocol outlined in Chapter three. A matrix se tup  outlined 
below included two concentrations of PHA. All the wells contained 5x10 4 
cells. "R" represented the  responding cell population, "Rx" the  Mitomycin- 
treated cell population. The results w ere expressed as  Si's  and w ere  calculated 
according to the formula listed in chapter three.
Result
The results indicated tha t a 1 :100 dilution w as optimal for the growth 
and proliferation of lymphocytes in the culture media (Table B2).
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Table B2
Stimulation indices of two PHA concentrations
R EHA1:100 PHA1;20o
Rx NA 0 .5 0  0 .5 4
PHA1;100 25 .38  NA NA
PHA1:200 7 .3 0  NA NA
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APPENDIX B
MIXED  L Y M P H O C Y T E  C U LT U R E  R E P O R T
Patient I.D. (R): 
S pouse I.D. (S): 
Unrelated Control 1 (UC1):  















































69 8 3 .0 0
0.21
2.03














1 072 9 .0 0
0 .14
3 .12
67 1 6 .0 0
0 .22
1.68
8 2 7 8 .0 0













7 5 8 4 .0 0
0 .19
6 .28























Subscript (x) indicates M i t o m y c in - C - t r e a t e d  cell populations.
S l=  Experim ental M LC /  Autologus M LC (RSx/RRx,... ,etc).
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